PharmaMar, S.A.
PHM.MCNext catalyst
Trabectedin
Mesenchymal Chondrosarcoma
Get an email about PHM.MC's next catalysts
Track PharmaMar (PHM.MC) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
No other upcoming event in our data.
1 upcoming, 0 past
Trabectedin Phase 2 Est. Readout (ISG-ARTICLE)
Estimated primary completion for Trabectedin trial (NCT04305548) in Mesenchymal Chondrosarcoma. Topline data typically follows completion by weeks to months.
SourceMarket Overview
Stock performance and key metrics
TDS-943 (topical diclofenac sodium spray)
Osteoarthritis
almorexant
Primary Insomnia
IVA337
NASH - Nonalcoholic Steatohepatitis
APVO101
Hemophilia B
Lurasidone
Schizophrenia
Epratuzumab
Systemic Lupus Erythematosus
Ciclesonide HFA Nasal Aerosol
Perennial Allergic Rhinitis
Bepotastine besilate
Perennial Allergic Rhinitis
Lurbinectedin
Leiomyosarcoma
Levetiracetam
Epilepsy
Ecraprost in lipid emulsion
Peripheral Vascular Disease
tacrolimus ointment
Dermatitis, Atopic
SC1011
Idiopathic Pulmonary Fibrosis
Aurograb
Staphylococcal Infections
Buprenorphine transdermal delivery system
Osteoarthritis
Lubiprostone
Constipation - Functional
SOF
Chronic HCV Infection
YY-162
Mental Disorders
Eslicarbazepine acetate
Epilepsy
Chronocort
Congenital Adrenal Hyperplasia
Arformoterol
Chronic Obstructive Pulmonary Disease
Lurbinectedin (PM01183)
Small-cell Lung Cancer
Cebranopadol
Acute Pain
SPM 927
Diabetic Neuropathy
MCI-186
Amyotrophic Lateral Sclerosis (ALS)
Inebilizumab
Systemic Sclerosis
Pegylated liposomal doxorubicin (PLD)
Ovarian Cancer
K301
Seborrhoeic Eczema of the Scalp
VCT220
Obesity
AJG555
Chronic Constipation
UGN-102
Bladder Cancer
acalabrutinib
Non Hodgkin Lymphoma
Botulinum Toxin A
Glabellar Frown Lines
Clifutinib
Leukemia, Acute Myeloid (AML)
Plitidepsin
Relapsed/Refractory Multiple Myeloma
Ropivacaine
Pain, Postoperative
Lubiprostone 24
Opioid-Induced Bowel Dysfunction
HEC74647PA+HEC110114
Chronic HCV Infection
AST-120
Chronic Kidney Disease
Orelabrutinib
Mantle Cell Lymphoma
APD421
Postoperative Nausea and Vomiting
VSL#3
Hepatic Encephalopathy
Rifamycin SV-MMX®
Traveler's Diarrhea
Insulin Degludec and Insulin Aspart
Diabetes
Fezolinetant
Hot Flashes
MP-214
Schizophrenia
Hydroquinone
Facial Melasma
Eicosapentaenoic Acid (EPA)
Adenomatous Polyps
Probiotic Arm
Mild and Moderate Chronic Periodontitis
ICP-332 Tablets
Chronic Spontaneous Urticaria (CSU)
MP-424
Chronic Hepatitis C (CHC)
alefacept
Chronic Plaque Psoriasis
Elacytarabine
Acute Myeloid Leukemia (AML)
Eszopiclone
Insomnia
Phentolamine Ophthalmic
Vision Loss Night
Tralokinumab
Atopic Dermatitis
Tideglusib
Congenital Myotonic Dystrophy
MT-6548
Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease
Ferinject
Iron Deficiency
Imiquimod
Carcinoma, Basal Cell
LEO 90100
Stable Plaque Psoriasis
FCM (Ferric carboxymaltose) high ferritin target
Iron Deficiency Anaemia
Calcipotriol plus betamethasone dipropionate gel (LEO 80185)
Psoriasis of Scalp
P2B001
Parkinson Disease
Sotatercept
Pulmonary Arterial Hypertension
micafungin
Mycoses
ciclesonide hydrofluoroalkane (HFA) nasal aerosol
Perennial Allergic Rhinitis
Pegzilarginase
Arginase 1 Deficiency
ChloraPrep
Surgical Skin Preparation
Ibuprofen
Pain
FK949E
Bipolar Depression
LEO 43204 gel
Actinic Keratosis
Buprenorphine transdermal system
Pain
Buprenorphine transdermal patch
Osteoarthritis
BPI-7711
NSCLC
Toludesvenlafaxine Hydrochloride
Generalized Anxiety Disorder
ICP-488 Tablets
Cutaneous Lupus Erythematosus (CLE)
Relugolix
Prostate Cancer
Test - Bimatoprost Ophthalmic
Glaucoma, Open-Angle
Patiromer
Hyperkalemia
Argatroban
Coronary Artery Disease
Kinisoquin™
Venous Thromboembolism
Teneligliptin/Canagliflozin
Type 2 Diabetes Mellitus
Lerotinib
Esophageal Cancer
Treatment and prophylaxis
COVID-19
ferrous sulphate
Anaemia
Darbepoetin alfa
Anemia; Non-dialysis Dependent Chronic Kidney Disease
PA21 (tablet containing iron)
Chronic Kidney Disease Requiring Chronic Dialysis
LEO 80185 gel
Psoriasis Vulgaris
Relugolix Combination Tablet
Uterine Fibroids
MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®)
Chronic Kidney Disease
ciclesonide
Perennial Allergic Rhinitis
dasiglucagon
Congenital Hyperinsulinism
AMPH ER Tab
ADHD
TA-7284-Low
Type 2 Diabetes Mellitus
YM178
Urinary Bladder, Overactive
tolterodine
Urinary Bladder, Overactive
Lonapegsomatropin
Adult Growth Hormone Deficiency
Certolizumab Pegol (CDP870)
Crohn's Disease
Ferinject ® (Ferric carboxymaltose)
Chronic Heart Failure
INZ-701
Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
Control Arm (Conventional Therapy)
Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency
Setidegrasib
Non-small Cell Lung Cancer (NSCLC)
hCRF [XERECEPT (corticorelin acetate injection)]
Brain Edema
Teneligliptin + Sulfonylurea
Type 2 Diabetes Mellitus
LY01005
Breast Cancer
Daivobet® gel
Psoriasis Vulgaris
Azelaic acid foam (BAY39-6251)
Papulopustular Rosacea
Dasotraline
Adult Attention Deficit Hyperactivity Disorder
Ferric carboxymaltose
Inflammatory Bowel Disease
Pimecrolimus
Atopic Dermatitis
Alteplase
Cerebral Infarction
DPT-IPV-Hib
Tetanus
Asacol®
Active Ulcerative Colitis
Levalbuterol
Asthma
Delgocitinib
Chronic Hand Eczema
ingenol mebutate
Actinic Keratosis
Sodium zirconium cyclosilicate
Hyperkalemia
Rotigotine
Idiopathic Parkinson's Disease
adagloxad simolenin combined with OBI-821
Triple Negative Breast Cancer
Extract from Hintonia latiflora bark
Diabetes Mellitus, Type 2
Teneli/Teneli + pio
Type 2 Diabetes Mellitus
TOP1630 Ophthalmic Solution OU
Dry Eye Syndrome
Obicetrapib
Atherosclerotic Cardiovascular Disease
Levalbuterol HCl Inhalation Solution
Reactive Airways Disease (RAD)
vernakalant hydrochloride
Atrial Fibrillation
calcipotriol and betamethasone (LEO 80185 gel)
Psoriasis Vulgaris
SM-13496
Bipolar Depression
LEO 90100 aerosol foam
Psoriasis Vulgaris
Probio-Tec® BG-VCap-6.5
Diarrhea
Mirabegron
Urinary Bladder, Overactive
peficitinib
Arthritis, Rheumatoid
solifenacin succinate
Lower Urinary Tract Symptoms
APL-130277
Parkinson Disease
Solifenacin Succinate Suspension
Urinary Bladder, Overactive
DFD06-Cream
Chronic Stable Plaque Psoriasis
Ingenol metabute
Actinic Keratosis
gilteritinib
Acute Myeloid Leukemia (AML)
Viltolarsen
Duchenne Muscular Dystrophy
Artesunate+Sulfamethoxypyrazine/pyrimethamin
Schistosoma Haematobium
ZuraPrep Clear Solution
Surgical Skin Preparation
Probiotic (Inersan)
Chronic Periodontitis
mesalazine
Crohn's Disease
Botulinum Toxin A - Open Label
Glabellar Frown Lines
LEO 90105 = calcipotriol + betamethasone dipropionate
Psoriasis
BBI608
Malignant Pleural Mesothelioma
glepaglutide
Short Bowel Syndrome
Oxycodone/Naloxone controlled-release
Low Back Pain
Roxadustat
Chronic Kidney Disease
[F-18]Flornaptitril
Alzheimer Disease
LEO 90100 foam
Psoriasis Vulgaris
DSP-7888 Dosing Emulsion
Glioblastoma
Irinotecan hydrochloride liposome Injection
Relapsed Small Cell Lung Cancer
Levosert-20
Heavy Menstrual Bleeding
Certolizumab pegol
Crohn's Disease
PLS240
Secondary Hyperparathyroidism
Levocetirizine dihydrochloride
Rhinitis
Eicosapentanoic Acid (EPA)
Familial Adenomatous Polyposis Coli
Udenafil
Single Ventricle Heart Disease After Fontan Surgery
YM150
Atrial Fibrillation
Vernakalant
Atrial Fibrillation
ASF1057
Seborrheic Dermatitis
AJM300
Colitis, Ulcerative
Exisulind
Non-Small Cell Lung Cancer
YM060
Diarrhea-predominant Irritable Bowel Syndrome
LAM561
High-grade Glioma
Linaprazan glurate
GERD (Gastroesophageal Reflux Disease)
Ciprodex®
Acute Otitis Externa
ASP1585
Chronic Kidney Disease
LY03003(Rotigotine,extended-release microspheres)
Parkinson Disease
Trazodone
Sleep Disorder
Spesolimab
Generalized Pustular Psoriasis
s.c. injection
Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma
DSP-5423P
Schizophrenia
ciclesonide nasal aerosol
Perennial Allergic Rhinitis
Zirconium silicate (acute phase)
Hyperkalemia
1PC002
Hypercholesterolemia
LY03005 extended-release tablet
Major Depressive Disorder (MDD)
APD421- Amisulpride for IV injection
PONV
House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae
House Dust Mite Allergy
Amisulpride Injection
Nausea and Vomiting, Postoperative
Cocaine Hydrochloride Nasal Solution
ENT Disorder
ipragliflozin
Type 2 Diabetes Mellitus
C213 Microneedle System
Cluster Headache
Teneligliptin
Type 2 Diabetes Mellitus
ASKB589
Gastroesophageal Junction Adenocarcinoma
ORADUR®-Methylphenidate
Attention Deficit Hyperactivity Disorder
Delgocitinib cream
Chronic Hand Eczema
Levalbuterol HCl
Chronic Obstructive Pulmonary Disease (COPD)
Vitamin D (Cholecalciferol)
Prediabetes
LEO43204 gel
Actinic Keratosis
TMZ
Primary Glioblastoma
DOXIL
Ovarian Neoplasms
LP-003
Chronic Spontaneous Urticaria
Lipid emulsion without progesterone
Brain Injuries
MT-7117 Low Dose
EPP
metyrapone
Cushing's Syndrome
Remimazolam
Pediatric ALL
Peginterferon Alfa-2A
Chronic Hepatitis, B Virus
JS105
Breast Cancer
ASP1941
Type 1 Diabetes Mellitus
MCI-196
Type 2 Diabetes
Another Phosphate binder (Sevelamer)
Chronic Kidney Disease
PEGASYS
High Risk Polycythemia Vera
Pegylated Lipoxomal Doxorubicin (PLD)
Ovarian Cancer
Arformoterol tartrate inhalation solution
COPD
Trabectedin
Mesenchymal Chondrosarcoma
Oxybutynin
Urge Urinary Incontinence
Doxorubicin
Metastatic Sarcoma
Ifosfamide
Sarcoma
DMB-3115
Moderate to Severe Chronic Plaque Psoriasis
Dexamethasone
Breast Neoplasms
Irinotecan
Advanced Solid Tumors
Topotecan
Relapsed Small Cell Lung Cancer
Dacarbazine
Advanced Liposarcoma or Leiomyosarcoma
SP-01 (Granisetron Transdermal Delivery System)
Chemotherapy-induced Nausea and Vomiting
ketotifen fumarate
Dermatitis
BNP7787
Breast Neoplasms
Cholecalciferol
Vitamin D Deficiency
Polyethylene Glycol-treated Human Immunoglobulin (VGIH)
Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
PRC-063 oral capsules
ADHD
ICP-248
Hematologic Malignancies
IB1001
Hemophilia B
Drospirenone
Contraception
levalbuterol tartrate MDI
Asthma
Calcipotriol plus hydrocortisone ointment vehicle
Psoriasis Vulgaris
Lurasidone HCl
Schizophrenia
Pudexacianinium chloride
Laparoscopic/Minimally Invasive Colorectal Surgery
olmesartan medoxomil
Essential Hypertension
Dalbavancin administration
Catheter Bacteremia
SM-13496 (lurasidone HCl)
Schizophrenia
Pre-screening Phase
Soil-Transmitted Helminths
ON 01910.Na
Myelodysplastic Syndrome
Parcopa
Parkinson's Disease
CNTO 148
Rheumatoid Arthritis
Esflurbiprofen Topical System (EFTS)
Contusions
DPT-IPV-Hib-High(Combined Vaccine)
Immunization; Infection
M207 Microneedle System
Migraine
XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght
End Stage Renal Disease
Ensifentrine
Chronic Obstructive Pulmonary Disease
Budesonide orodispersible
Eosinophilic Esophagitis
Levalbuterol tartrate HFA MDI
Exercise-induced Bronchospasm
Metformin ≥
Type 2 Diabetes Mellitus
Teysuno
Colorectal Cancer
Calcipotriol plus betamethasone
Psoriasis Vulgaris
DPT-IPV-Hib (Combined Vaccine)
Immunization
Inersan
Chronic Periodontitis
norUrsodeoxycholic Acid
Primary Sclerosing Cholangitis
Imiquimod cream + surgery
Lentigo Maligna Melanoma (Head or Neck)
ASP7374
Influenza
zolbetuximab
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
Mitizodone Phosphate tablets
Depressive Disorder, Major
UB-851
Renal Anemia
Daridorexant
Insomnia Disorder
Phlogenzym
Thrombophlebitis Leg
TA-7284 Low
Type 2 Diabetes Mellitus
Lacosamide
Painful Diabetic Neuropathy
Levocetirizine
Dermatitis, Atopic
Tralokinumab + TCS
Atopic Dermatitis
Basimglurant
Trigeminal Neuralgia
Lurasidone initially rerandomized either to or at week 2
Schizophrenia
1PC111
Primary Hypercholesterolemia
Co-Arinate FDC
Plasmodium Falciparum Malaria
Oxypurinol
Congestive Heart Failure
Epanova
Crohn's Disease
Vernakalant Injection
Atrial Fibrillation
TransCon hGH
Growth Hormone Deficiency, Pediatric
olmesartan medoxomil oral tablets, hydrochlorothiazide oral tablets
Essential Hypertension
HEC585
Idiopathic Pulmonary Fibrosis
Doxorubicin (DOX)
Small-cell Lung Cancer
ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System)
Osteoarthritis
Levonorgestrel
Contraception
Zilucoplan®
Generalized Myasthenia Gravis (gMG)
C21
Idiopathic Pulmonary Fibrosis
MCI-9042
Cerebral Infarction
PerioChip ®
Generalized Adult Periodontitis
MesoPher
Mesothelioma
CDP870
Rheumatoid Arthritis
co-administration of aztreonam and nacubactam
Complicated Urinary Tract Infection
Teneli/Teneli + SU
Type 2 Diabetes Mellitus
Broncho-Vaxom
Atopic Dermatitis
S-Caine™ Peel (lidocaine and tetracaine cream)
Pain
Dovobet ® ointment
Psoriasis Vulgaris
hu1418K322A + Temozolomide + Irinotecan
High-Risk Neuroblastoma
Brivaracetam
Epilepsy
Calcipotriene/betamethasone gel and ointment
Psoriasis
hCRF
Brain Edema
Arformoterol 25 ųg BID
Chronic Obstructive Pulmonary Disease
Oxybutynin Hydrochloride
Spina Bifida
Active Theramine and Active Naproxen
Low Back Pain
Combination antiviral therapy
Primary Biliary Cirrhosis
YM443
Dyspepsia
ZuraPrep
Surgical Site Infection
Tryptophan
Schizophrenia
Abarelix
Prostate Cancer
Thioctic Acid
Diabetic Polyneuropathy
mesalamine granules
Colitis, Ulcerative
Vibegron
Neurogenic Detrusor Overactivity
Atenolol
Essential Hypertension
Caspofungin
Candidiasis
Icosapent Ethyl
Liver Metastasis
Ferinject (ferric carboxymaltose)
Iron Deficiency
[O-15]-Water PET Myocardial Perfusion Imaging (MPI)
Coronary Artery Disease
Test Product
Bronchial Asthma
LPRI424 (dienogest/ethinylestradiol)
Contraception
Tinzaparin
Colorectal Cancer Metastatic
MOB015B
Distal Subungual Onychomycosis
Salmeterol
Chronic Obstructive Pulmonary Disease
Epanova™ (Omega-3 Free Fatty Acids)
Crohn's Disease
Benzocaine Otic Solution
Pain
Use Phase (Ulipristal Acetate)
Emergency Contraception
Toctino
Chronic Hand Eczema
Hydrocodone bitartrate q24h film-coated tablets
Chronic Low Back Pain
co-administration of cefepime and nacubactam
Complicated Urinary Tract Infection
ASC30 tablets A1
Obesity
Esmolol Hydrochloride
Diabetic Foot Ulcer
Aldara (Imiquimod)
Actinic Keratosis
levetiracetam (Keppra)
Alcohol Dependence
Luspatercept
Myelodysplastic Syndromes
PL2200 Aspirin Capsules
Diabetes Mellitus, Type 2
Itopride
Healthy Volunteers
Asenapine
Schizophrenia
SPM 962
Parkinson Disease, Idiopathic
Nifedipine
Chronic Anal Fissure
Chlorhexidine gluconate chip
Peri-Implantitis
Ursodeoxycholic acid
Chronic Hepatitis C
Lactulose
Chronic Liver Disease
ELGN-2112
Intestinal Malabsorption
Diltiazem hydrochloride
Chronic Anal Fissure
Sevelamer carbonate
Chronic Kidney Disease Requiring Chronic Dialysis
approved egg-derived TIV
Influenza
nateglinide
Type 2 Diabetes Mellitus
Calcipotriol plus betamethasone dipropionate (LEO80185 gel)
Psoriasis of Scalp
Oxycodone HCl controlled-release tablets
Pain
Buagafuran capsules
Generalized Anxiety Disorder
ART-123
Severe Sepsis
Qutenza (capsaicin) topical system
Post Surgical Neuropathic Pain
Azelastine Hydrochl./Fluticasone Prop
Allergic Rhinitis
K40a
Seborrhoeic Dermatitis of the Scalp
Prophylactic anticoagulation (INNOHEP®)
Anemia
subcutaneous apomorphine
Motor OFF Episodes Associated With Parkinson's Disease
CDB-2914
Emergency Contraception
administration of Cimzia®
Axial and Peripheral Spondyloarthritis
KP-100LI
Vocal Fold Scar
FlutiForm 250/10
Asthma
FK506
Keratoconjunctivitis
Baker's yeast (Bio Chromium)
Diabetes Mellitus, Type 2
TRS01
Non-infectious Anterior Uveitis
SYN023
Rabies
MP-513
Type 2 Diabetes Mellitus
Relugolix Combination Therapy
Contraception
Ciclesonide HFA
Seasonal Allergic Rhinitis
Vitamin D
Sarcopenia
Tehalose 30gr
Muscular Dystrophy, Oculopharyngeal (OPMD)
TA-650
Crohn's Disease
ZuraPrep with IPA
Surgical Site Infection
Budesonide granules
Incomplete Microscopic Colitis
Linsitinib
Relapsed Ewing Sarcoma
Moxifloxacin
Parkinson's Disease
Standard arm: Trabectedin in monotherapy
Advanced Soft Tissue Sarcoma
gemcitabine + docetaxel
Leiomyosarcoma
LEO90100 cutaneous spray, ointment
Psoriasis Vulgaris
Sepranolone injection low dose
Menstrual Migraine
Engineered cartilage graft (N-TEC)
Patellofemoral Osteoarthritis
Fluticasone Propionate
COPD
No Intervention: Observational Cohort
Leiomyosarcoma of Ovary
Levalbuterol HFA MDI followed by Racemic albuterol HFA MDI
Asthma
ZPL-3893787
Atopic Dermatitis
Budesonide plus Prevacid
Eosinophilic Esophagitis
AG-73305
Diabetic Macular Edema
Racemic formoterol
COPD
miravirsen
Hepatitis C
CPL500036 - low dose
Schizophrenia
AK102
Hypercholesterolemia
Clifutinib Besylate
Acute Myeloid Leukemia, Adult
Zuberitamab
Marginal Zone Lymphoma(MZL)
Calcium Dobesilate
COVID-19 Virus Disease
HEC110114 Tablet
Chronic Hepatitis C
Biphasic Remogliflozin Etabonate
Type 2 Diabetes Mellitus
ASF 1096 cream applied
Discoid Lupus Erythematosus
ASP8062
Alcohol Use Disorder
YP-P10 Ophthalmic
Dry Eye
lidocaine and tetracaine
Postherpetic Neuralgia
Interferon-gamma (IFN-γ)
Breast Cancer
TG-1000
Influenza Virus Infection
Estriol
Vaginal Atrophy
BBI503
Hepatocellular Carcinoma
ASP1707
Rheumatoid Arthritis
SPP635 (drug)
Hypertension
Fosaprepitant
CINV
OBI-833/OBI-821
Non-small Cell Lung Cancer
Ciprofloxacin Ear Drops
Otitis Externa
PEG-hirudin
Chronic Kidney Failure
Recombinant Influenza HA Vaccine (H5N1)
Influenza
YY-351
Diabetes
CAL101
Idiopathic Pulmonary Fibrosis
APG-115
Liposarcoma
A-dopamine
Parkinson Disease
Dexamethasone or equivalent steroid
Neoplasm Metastases
Phase 2: Trabectedin
Soft-tissue Sarcomas
Nemonoxacin
Pneumonia
Cis-UCA emulsion
Atopic Dermatitis
Phase 2: Cyclophosphamide
Soft-tissue Sarcomas
Experimental arm: Trabectedin + Olaparib
Advanced Soft Tissue Sarcoma
Z650
Esophageal Squamous Cell Carcinoma
Cerebral Dopamine Neurotrophic Factor
Parkinson Disease
ZR-02-01 Fentanyl Transdermal Matrix Patch
Pain
ART6043
Advanced Solid Tumor
ZED1227 + SIGE
Celiac Disease
GamTBvac vaccine
Healthy
Enzomenib
Leukemia, Myeloid, Acute
Phase 1: Cyclophosphamide
Soft-tissue Sarcomas
tacrolimus modified release (MR)
Liver Transplantation
Aromatase Inhibitors
Breast Neoplasm
APHD-012P
Obese
LP-003 dose 1
Seasonal Allergic Rhinitis
Cobiprostone
NSAID-induced Gastroduodenal Injury
Ciprofloxacin Foam Otic Cipro
Otitis Externa
Liposomeal curcumin
Patients w/Advanced Cancer That Failed Std of Care Therapy
SPH3127 tablet Dose 1
Hypertension,Essential
Dispensing Codivir®
HIV
SAP-001
Gout
Oral isotretinoin
Actinic Keratosis
Act-HIB®
Healthy
Sertaconazole
Skin Alterations Associated With Atopic Dermatitis
EMP16-02 orlistat/acarbose
Overweight or Obesity
Nifedipine coated suppositories
Chronic Anal Fissure
AC-3933
Alzheimer's Disease
Picato
Anogenital Warts
CT053PTSA
Non-small Cell Lung Cancer
Amikacin fosfomycin inhalation solution
Pneumonia, Bacterial
Temozolomide in both arms
Glioblastoma
Heated lidocaine/tetracaine patch
Myofascial Pain Syndromes
ACP-196 (acalabrutinib)
Chronic Lymphocytic Leukemia
PolyCore (Polydextrin, L-Carnitine, D-xylitol)
Congestive Heart Failure
MT-3921
Spinal Cord Injury
MP-424 (Telaprevir)
Hepatitis C
Saccharomyces cerevisiae
Irritable Bowel Syndrome
NRC-2694-A
Carcinoma
NS-050/NCNP-03
Duchenne Muscular Dystrophy
CPL409116
Rheumatoid Arthritis
OCZ103-OS [pentamidine bis(2-hydroxyethanesulfonate)], mFOLFOX6 or FOLFIRI
Colorectal Cancer
MCC-257
Diabetic Polyneuropathy
Bupivacaine
Mucositis
once daily for two consecutive days (Picato)
Actinic Keratosis
Donepezil Transdermal
Irritation/Irritant
cefepime and enmetazobactam combination
Complicated Urinary Tract Infection
MT-4561
Head and Neck Squamous Cell Carcinoma (HNSCC)
MT-2990
Endometrial Related Pain
intravitreal injection of KH902
Neovascular Age-related Macular Degeneration
JTR-161
Acute Ischemic Stroke
ILT101
Bipolar Depression
Chitosan- N- Acetylcysteine eye drops
Dry Eye Syndrome
rhIL-2
Type 1 Diabetes
Photofrin
Superficial Bladder Cancer
Pegylated Liposomal Doxorubicine
Glioblastoma
PA21 (iron)
Chronic Kidney Disease
Xeomin
Cerebral Palsy
Polyphenon E (EGCG)
Prostate Cancer
Nicardipine
Aneurysmal Subarachnoid Hemorrhage
Acetaminophen and Ibuprofen
Stomach Neoplasms
FK778
Liver Transplantation
V116517 50-mg tablets
Postherpetic Neuralgia
dexfadrostat phosphate
Primary Aldosteronism
PHP-201 ophthalmic
Normal Tension Glaucoma
CP-4055
Malignant Melanoma
LAT8881
Acute Migraine
E6011
Crohn's Disease
LEO 138559
Atopic Dermatitis
MT-4666
Alzheimer's Disease
V120083
Osteo Arthritis Knee
TSX-002
Hypogonadism
OC-01 (varenicline) nasal spray
Dry Eye Disease
VNX001
Interstitial Cystitis
NS-065/NCNP-01
Duchenne Muscular Dystrophy
Levalbuterol HFA MDI
Asthma
JTT-851
Type 2 Diabetes Mellitus
ICP-192
Intrahepatic Cholangiocarcinoma (ICC)
VVD-101
Delayed Alcohol Induced Headache
NTRX-07
Alzheimer Disease
Pudafensine
Vulvodynia
Interleukin 2
Rheumatoid Arthritis
PD solution containing glucose
End Stage Renal Disease
HEC169096
Advanced Solid Tumor
LEO 43204
Actinic Keratosis
LEO 29102 cream
Psoriasis Vulgaris
APHD-012
Obese With Comorbidities
Alintegimod
Advanced Cancer
PA101
Refractory Chronic Cough
LUM-201
Growth Hormone Deficiency
collagenase
Chronic Coronary Total Occlusions
MCC-135
Myocardial Infarction
Haemophilus b conjugate vaccine diphteria CRM197 protein conjugate)-Low + DPT-IPV
Haemophilus Influenza Type b
Saquinavir
IDV Associated Nephrotoxicity
NOX-H94
Anemia of Chronic Disease
Daivonex cream
Psoriasis
JYP0015
Solid Tumor
ET 743
Prostate Cancer
BTA-C585 oral capsule
Respiratory Syncytial Virus (RSV) Infection
Sunobinop
Alcohol Use Disorder
MT-2111
Diffuse Large B-Cell Lymphoma
LP0113 aerosol spray
Skin and Connective Tissue Diseases
NS-229
Eosinophilic Granulomatosis With Polyangiitis
APG-2575
SLE
LOAd703
Pancreatic Adenocarcinoma
OBI-902
Advanced Solid Tumor
X0002 Spray
KNEE OSTEOARTHRITIS
Betamethasone plus calcipotriol
Psoriasis Vulgaris
Tacrolimus
Dermatitis, Atopic
VentaProst (inhaled epoprostenol delivered via a dedicated delivery system)
COVID-19
NT-KO-003
Relapsing Remitting Multiple Sclerosis
XEN-D0501
Efficacy
ONO-4641
Multiple Sclerosis
ACP-196
Metastatic Pancreatic Cancer
FP187
Plaque Psoriasis
PRI-724
Acute Myeloid Leukemia
JTT-302
Dyslipidemia
Levosimendan
Transient Ischemic Attack
Formatris
Asthma
CIN-102
Idiopathic Gastroparesis
CPL500036 - high dose
Parkinson Disease
Esketamine DPI - low dose
Bipolar Depression
Cannabisextrakt Avextra ösung
Medical Oncology
TD1414
Impetigo
ODM-201
Prostate Cancer
CyCol™
Mild to Moderate Ulcerative Colitis
Phentolamine Mesylate Ophthalmic
Mydriasis
Sepranolone (UC1010) low dose
Premenstrual Dysphoric Disorder
ZED1227
NAFLD
QHRD106 Injection (Low-dose group)
Acute Ischemic Stroke
NS-018
Primary Myelofibrosis
SKB264
Non-small Cell Lung Cancer
OPT-822/OPT-821
Metastatic Breast Cancer
STP938
Lymphoma, B-Cell
Olaptesed pegol - Monotherapy
Metastatic Colorectal Cancer
DAG181
Chronic HCV Infection
Dexamethasone Iontophoretic Patch (low dose)
Lateral Epicondylitis
Sepranolone
Tourette Syndrome
JTE-051
Rheumatoid Arthritis
recAP
Acute Kidney Injury
T3011
Solid Tumor
WD-890 tablet
Brief Description of Focus of Study
MT-1303-Low
Plaque Psoriasis
MP-435(dose1) + Methotrexate
Rheumatoid Arthritis
Cromoglicate
Psoriasis
APD405
Postoperative Nausea and Vomiting
Cultured Thymus Tissue for Implantation (CTTI)
DiGeorge Anomaly
K201
Atopic Dermatitis
IDP-121
Multiple Myeloma (MM)
SMP-986
Overactive Bladder Syndrome (OABS)
AeroFact
Respiratory Distress Syndrome in Premature Infant
Minoxidil Topical
Alopecia, Androgenetic
TSD-001
Bladder Cancer Cell Transitional
MP-513 Lowest Dose and Metformin
Type 2 Diabetes Mellitus
EP0031
NSCLC
ME3183
Plaque Psoriasis
OSI-211 (Liposomal Lurtotecan)
Ovarian Neoplasms
Isoquercetin
Sickle Cell Disease
Cultured Thymus Tissue Implantation (CTTI)
DiGeorge Anomaly
Racemic Albuterol followed by levalbuterol HFA MDI
Asthma
12 cm2 - 2 Active DMTS Patches
Agitation
Donor lymphocyte preparation depleted of functional host alloreactive T-cells (ATIR)
Hematologic Diseases
MKP10241
Type 2 Diabetes Mellitus (T2DM)
JM-010 group A
Dyskinesias
MT-7117
Diffuse Cutaneous Systemic Sclerosis
ICP-322
Prurigo Nodularis (PN)
AP31969
Atrial Fibrillation (AF)
Ilofotase alfa
Open Heart Surgery
AD981
Obesity Hypoventilation Syndrome (OHS)
SMP3124LP
Solid Tumor
GS-248
Systemic Sclerosis
AP09004
Parkinson's Disease
LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel)
Scalp Psoriasis
CDB-2914 (ulipristal acetate)
Contraception
LP-003 Dose 1 (Single)
Allergic Diseases
Methotrexate (MTX)
Rheumatoid Arthritis
ACD440
Peripheral Neuropathic Pain
OBI-992
Advanced Solid Tumor
SPRC-AB01
Chronic Sinusitis
LEO 90105
Psoriasis Vulgaris
unoprostone isopropyl
Dry Age-related Macular Degeneration
TimoD implant
Glaucoma
OTP-01
Advanced Solid Tumors
HEC585 dose A
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
JTT-861 Capsules
Chronic Heart Failure
LEO 80185 (Xamiol® gel/Taclonex® Scalp topical suspension)
Psoriasis Vulgaris
Orelabrutinib (ICP-022)
Part 1:r/r B-cell Malignancies
JYP0061
Neuromyelitis Optica Spectrum Disorders
DFD-07 Cream
Actinic Keratosis
PDC*lung01
Non Small Cell Lung Cancer
ACP-319
Non-Hodgkins Lymphoma
LUT014 Gel
Radiation Dermatitis
N17350
Neoplasms, Solid Tumor
GIC-1001
Pain
Cabaletta
Oculopharyngeal Muscular Dystrophy
Pirfenidone with MODD
Diabetic Foot Ulcer
MT-3995 Low
Diabetic Nephropathy
Ecopipam
Tourette's Syndrome
AP1189
Rheumatoid Arthritis
IZN-6NVS Cream
Atrophic Vaginitis
TRS01 eye drops
Non-infectious Anterior Uveitis
LEO 152020 tablet
Atopic Dermatitis
Brimonidine tartrate Gel
EGFR Inhibitor-associated Rash
Cariprazine Depot
Schizophrenia
SG Depot
Diabete Type 2
ILT-101
Systemic Lupus Erythematosus
PL2200
Gastroduodenal Ulceration
AP30663
Atrial Fibrillation
LEO 124249
Alopecia Areata
MT-1303
Crohn's Disease
APH-012P
PreDiabetes
JTT-705 and pravastatin
Type II Hyperlipidemia
LEV102
Acquired Blepharoptosis
Vonafexor
Non-alcoholic Steatohepatitis
SPP635
Hypertension
RPh201, botanical drug product
Healthy Volunteers
IZN-6D4 Gel
Diabetic Foot Ulcer
CVXL-0107
Idiopathic Parkinson Disease
MT-3995
NASH
AC102 gel
Hearing Loss, Sensorineural
Mesalamine Oral Product
Eosinophilic Esophagitis
Amphetamine
ADHD
TYNADOTE
Hepatitis
ulipristal acetate
Leiomyoma
Acalabrutinib (ACP-196)
Waldenström Macroglobulinemia (WM)
QR-333
Diabetic Neuropathy
Acalabrutinib (Arm A)
Chronic Lymphocytic Leukemia
EYP001a
Hepatitis B, Chronic
Ingenol mebutate gel
Actinic Keratosis
ATIR101
Acute Myeloid Leukemia
Treatment A: Azelastine hydrochloride nasal spray (Azelair)
Seasonal Allergic Rhinitis
ASC30 tablets
T2DM (Type 2 Diabetes Mellitus)
Ga-68 P16-093 PET/CT scan
Prostate Cancer Recurrent
Inhaled Aviptadil
Covid19
AP611074
Anogenital Warts
ASKG915
Advanced Solid Tumors
NanoLithium® NP03
Alzheimer's Disease
Botulinum toxin A "BoNT/A-DP"
Frown Lines
Delgocitinib cream vehicle
Frontal Fibrosing Alopecia
Naronapride
Gastroparesis
rigosertib
Myelodysplastic Syndrome
PP-001
Non-infectious Uveitis
ONO-6950
Asthma
EP0042
Acute Myeloid Leukemia
BPI-7711 Capsule
Non-small Cell Lung Cancer
Oxymetazoline gel
Fecal Incontinence
ART0380
Advanced Cancer
Daivobet® gel applied then removed after 10 minutes (+/- 2 minutes)
Psoriasis Vulgaris
LEO43204
Acne Vulgaris
decitabine in combination with genistein
Non Small Cell Lung Cancer
HEC96719
Non-Alcoholic Steatohepatitis
Pactimibe
Atherosclerosis
Mycograb, Docetaxel
Cancer of the Breast
LY01021
Assisted Reproduction
ROSE-010
Obesity; Overweight
Lactobacillus gasseri BGP345A
Opioid-Induced Constipation
ASC42
Primary Biliary Cholangitis
LEO 124249 ointment
Chronic Hand Eczema
LTX-109
Nasal Decolonization of Staphylococcus Aureus
avacincaptad pegol
Stargardt's Macular Dystrophy
L-carnitine
End-Stage Renal Disease
HL-085
Melanoma
ASP8825
Restless Legs Syndrome
MT-3995 High
Diabetic Nephropathy
human lactoferrin peptide 1-11
Hematopoietic Stem Cell Transplantation
MT-1303-Middle
Relapsing-remitting Multiple Sclerosis
XEN-D0501,/tablet
Diabetes Mellitus, Type 2
JTT-705 and simvastatin
Dyslipidemia
PA101B
Uremic Pruritus
NP137
Endometrial Carcinoma
RTV
Chronic Hepatitis B
Ciprodex Otic Suspension
Otitis Externa
C-82 Topical
Systemic Scleroderma
SP-02L (darinaparsin for injection)
Peripheral T-Cell Lymphoma
STC-1010 + IS regimen + SOC therapy
Unresectable Metastatic Colorectal Cancer
Aprepitant
Pruritus
SEP-225289
Adult Attention Deficit Hyperactivity Disorder
ASF 1096
Discoid Lupus Erythematosus
ASP3291
Ulcerative Colitis
GM102
Colorectal Cancer
Covidir injections
COVID-19
Diacerein
Complications of Diabetes Mellitus
X842
Erosive Esophagitis
SPC2996
Chronic Lymphocytic Leukemia
MT-1303-High
Relapsing-remitting Multiple Sclerosis
ASP8232
Healthy Subjects
GRT6005
Diabetic Polyneuropathy
Pradigastat
Functional Constipation
UMN-0501
Influenza
Elacytarabine plus idarubicin
Acute Myeloid Leukemia
EP0057
Ovarian Cancer
ONO-2952
Irritable Bowel Syndrome (IBS)
JTT-705 and atorvastatin
Dyslipidemia
Alkaline Phosphatase
Sepsis
Azelaic acid
Papulopustular Rosacea
Ursodesoxycholic acid
Serum Levels of ALAT Transaminases
SEP-4199
Depressive Episode
Rifalazil 25 milligram
Chlamydia Trachomatis Infection
YM155
Melanoma
ICP-022
Waldenstrom's Macroglobulinemia Recurrent
OSI-906
Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
Triamcinolone Acetonide (TAC) DuraPeel
Hand Dermatoses
ProTrans
Type1diabetes
ASP3652
Cystitis, Interstitial
Naproxen
Healthy Volunteers
VDA-1102
Actinic Keratosis
Norgestrel
Contraception
MT-3995 Middle
Diabetic Nephropathy
LEO 19123 Cream (calcipotriol plus LEO 80122)
Psoriasis Vulgaris
TL-895
Myelofibrosis
ME-015 (Suplatast Tosilate)
Idiopathic Pulmonary Fibrosis
Chlorhexidine
Peri-implantitis
NOE-115
Menopause Syndrome
SXR1096 cream
Netherton Syndrome
Vipoglanstat
Endometriosis
Depigoid Phleum
Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma
ODM-212
Solid Tumours
PM01183
Breast Cancer
Zalypsis
Ewing's Sarcoma
VX-745
Alzheimer's Disease
APD515
Xerostomia in Advanced Cancer Patients
Aplidin®
Leukemia
Calcipotriol plus betamethasone dipropionate (LEO 80185) gel
Psoriasis Vulgaris
APLIDIN (plitidepsin)
Myelofibrosis
Transdermal Ketoprofen Patch with CHADD
Pain
TL-925
Allergic Conjunctivitis
PM54
Advanced Malignancies
EXE-346
Ileal Pouch
PM060184
Advanced Colorectal Cancer
Flurbiprofen Tape (Arm 2)
Chronic Low Back Pain
IV CP-4126
Advanced Adenocarcinoma of Pancreas
BPI-1178
Advanced Solid Tumor
DFD06 Cream
Psoriasis
GRASPA
Acute Lymphoblastic Leukemia
VIOKASE 16
Exocrine Pancreatic Insufficiency
OCZ103-OS
Non-small Cell Lung Cancer
CP-461
Prostate Cancer
GA Depot
Multiple Sclerosis
Fosmidomycin and Clindamycin co-administration
Malaria
Phenyephrine
Incontinence
pentamidine
Colorectal Cancer
Calcipotriol and LEO80122 (LEO19123 cream)
Hand Eczema
ONO-5129
Diabetes Mellitus, Type 2
VA2914
Contraception
TOP-N53
Digital Ulcers in Systemic Sclerosis
RPL554
Asthma
MOB015
Onychomycosis
LP-005 Injection
PNH - Paroxysmal Nocturnal Hemoglobinuria
ASP7373
Healthy
ASC41
Non-alcoholic Fatty Liver Disease
Orelabrutinib (Low Dose)
Systemic Lupus Erythematosus, SLE
ONO-2333Ms Experimental 2
Major Depressive Disorder
DMTS
Pain, Postoperative
BGP-014
Ulcerative Colitis
Flurbiprofen
Periodontitis
LEO 29102
Atopic Dermatitis
CM355
Hematoma
LPM3770164
Tardive Dyskinesia (TD)
ONO-1101
Postoperative Supraventricular Tachyarrythmia
Zirconium silicate (ZS)
Hyperkalemia
Theralux extracorporeal photochemotherapy
Graft vs Host Disease
ICP-723
Solid Tumors
KAND567
Epithelial Ovarian Cancer
Vernakalant (oral)
Atrial Fibrillation
Dersalazine sodium
Ulcerative Colitis
Mesalamine
Colonic Diverticulosis
ADX10059
Gastroesophageal Reflux
NOX-E36
Type 2 Diabetes Mellitus
JTE-451 Tablets
Plaque Psoriasis
LP-003 Injection
Allergic Asthma
Imiquimod (topical use)
Actinic Keratosis
Zaleplon AP formulation
Insomnia
norUDCA
Primary Sclerosing Cholangitis
Low Dose GRT6005
Low Back Pain
ATIR
Acute Myeloid Leukemia
PerioSept(r)
Periodontitis
Lexaptepid pegol (NOX-H94)
Anemia
Isotretinoin
Congenital Ichthyosis
ProTrans: Allogeneic transplantation with WJMSCs
Type1 Diabetes Mellitus
Utidelone
HER2-negative Breast Cancer Patients With Brain Metastases
ACT01
Actinic Keratosis
ASP7517
Advanced Malignancies
SPL026
Major Depressive Disorder
GLS4
Chronic HBV Infection
CRD007
Duchenne Muscular Dystrophy
SFX-01
Subarachnoid Hemorrhage, Spontaneous
CIN-107
Uncontrolled Hypertension
Ibuprofen-PC
Osteoarthritis
Coated Nifedipine Suppositories
Anal Resting Pressure
Cabaletta for IV infusion once weekly during 24 weeks
Machado-Joseph Disease / Spinocerebellar Ataxia 3
MT-8554
Painful Diabetic Peripheral Neuropathy
Neflamapimod
Dementia With Lewy Bodies
QuickShot™ - Treatment B
Hypogonadism
PL3100
Gastroduodenal Ulcerations
ONO-2506PO
Alzheimer's Disease
APO-go
Parkinson Disease
Calcipotriol
Psoriasis Vulgaris
ASP7147
Diarrhea Predominant Irritable Bowel Syndrome
LEO 32731
Psoriasis Vulgaris
DSP-7888
Myelodysplastic Syndrome
ORM-12741
Alzheimer's Disease
Nusivertib
Myelofibrosis
Tdap vaccine
Atopic Dermatitis
RPh201
Non-arteritic Ischemic Optic Neuropathy
XER-001
Locally Advanced Pancreatic Adenocarcinoma
Mavodelpar
Primary Mitochondrial Myopathy
A166
HER2-positive Breast Cancer
INV-202
Obesity
marketed topical retinoid
Acne Vulgaris
NMD670
Spinal Muscular Atrophy
TA-NIC
Smoking
IZN-6N4
Oral Mucositis
Phase 1: Trabectedin
Soft-tissue Sarcomas
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
TDS-943 (topical diclofenac sodium spray) | Phase 3 | Osteoarthritis | - | - |
almorexant | Phase 3 | Primary Insomnia | - | - |
IVA337 | Phase 3 | NASH - Nonalcoholic Steatohepatitis | - | - |
APVO101 | Phase 3 | Hemophilia B | - | - |
Lurasidone | Phase 3 | Schizophrenia | - | - |
Epratuzumab | Phase 3 | Systemic Lupus Erythematosus | - | - |
Ciclesonide HFA Nasal Aerosol | Phase 3 | Perennial Allergic Rhinitis | - | - |
Bepotastine besilate | Phase 3 | Perennial Allergic Rhinitis | - | - |
Lurbinectedin | Phase 3 | Leiomyosarcoma | - | - |
Levetiracetam | Phase 3 | Epilepsy | - | - |
Ecraprost in lipid emulsion | Phase 3 | Peripheral Vascular Disease | - | - |
tacrolimus ointment | Phase 3 | Dermatitis, Atopic | - | - |
SC1011 | Phase 3 | Idiopathic Pulmonary Fibrosis | - | - |
Aurograb | Phase 3 | Staphylococcal Infections | - | - |
Buprenorphine transdermal delivery system | Phase 3 | Osteoarthritis | - | - |
Lubiprostone | Phase 3 | Constipation - Functional | - | - |
SOF | Phase 3 | Chronic HCV Infection | - | - |
YY-162 | Phase 3 | Mental Disorders | - | - |
Eslicarbazepine acetate | Phase 3 | Epilepsy | - | - |
Chronocort | Phase 3 | Congenital Adrenal Hyperplasia | - | - |
Arformoterol | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Lurbinectedin (PM01183) | Phase 3 | Small-cell Lung Cancer | - | - |
Cebranopadol | Phase 3 | Acute Pain | - | - |
SPM 927 | Phase 3 | Diabetic Neuropathy | - | - |
MCI-186 | Phase 3 | Amyotrophic Lateral Sclerosis (ALS) | - | - |
Inebilizumab | Phase 3 | Systemic Sclerosis | - | - |
Pegylated liposomal doxorubicin (PLD) | Phase 3 | Ovarian Cancer | - | - |
K301 | Phase 3 | Seborrhoeic Eczema of the Scalp | - | - |
VCT220 | Phase 3 | Obesity | - | - |
AJG555 | Phase 3 | Chronic Constipation | - | - |
UGN-102 | Phase 3 | Bladder Cancer | - | - |
acalabrutinib | Phase 3 | Non Hodgkin Lymphoma | - | - |
Botulinum Toxin A | Phase 3 | Glabellar Frown Lines | - | - |
Clifutinib | Phase 3 | Leukemia, Acute Myeloid (AML) | - | - |
Plitidepsin | Phase 3 | Relapsed/Refractory Multiple Myeloma | - | - |
Ropivacaine | Phase 3 | Pain, Postoperative | - | - |
Lubiprostone 24 | Phase 3 | Opioid-Induced Bowel Dysfunction | - | - |
HEC74647PA+HEC110114 | Phase 3 | Chronic HCV Infection | - | - |
AST-120 | Phase 3 | Chronic Kidney Disease | - | - |
Orelabrutinib | Phase 3 | Mantle Cell Lymphoma | - | - |
APD421 | Phase 3 | Postoperative Nausea and Vomiting | - | - |
VSL#3 | Phase 3 | Hepatic Encephalopathy | - | - |
Rifamycin SV-MMX® | Phase 3 | Traveler's Diarrhea | - | - |
Insulin Degludec and Insulin Aspart | Phase 3 | Diabetes | - | - |
Fezolinetant | Phase 3 | Hot Flashes | - | - |
MP-214 | Phase 3 | Schizophrenia | - | - |
Hydroquinone | Phase 3 | Facial Melasma | - | - |
Eicosapentaenoic Acid (EPA) | Phase 3 | Adenomatous Polyps | - | - |
Probiotic Arm | Phase 3 | Mild and Moderate Chronic Periodontitis | - | - |
ICP-332 Tablets | Phase 3 | Chronic Spontaneous Urticaria (CSU) | - | - |
MP-424 | Phase 3 | Chronic Hepatitis C (CHC) | - | - |
alefacept | Phase 3 | Chronic Plaque Psoriasis | - | - |
Elacytarabine | Phase 3 | Acute Myeloid Leukemia (AML) | - | - |
Eszopiclone | Phase 3 | Insomnia | - | - |
Phentolamine Ophthalmic | Phase 3 | Vision Loss Night | - | - |
Tralokinumab | Phase 3 | Atopic Dermatitis | - | - |
Tideglusib | Phase 3 | Congenital Myotonic Dystrophy | - | - |
MT-6548 | Phase 3 | Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease | - | - |
Ferinject | Phase 3 | Iron Deficiency | - | - |
Imiquimod | Phase 3 | Carcinoma, Basal Cell | - | - |
LEO 90100 | Phase 3 | Stable Plaque Psoriasis | - | - |
FCM (Ferric carboxymaltose) high ferritin target | Phase 3 | Iron Deficiency Anaemia | - | - |
Calcipotriol plus betamethasone dipropionate gel (LEO 80185) | Phase 3 | Psoriasis of Scalp | - | - |
P2B001 | Phase 3 | Parkinson Disease | - | - |
Sotatercept | Phase 3 | Pulmonary Arterial Hypertension | - | - |
micafungin | Phase 3 | Mycoses | - | - |
ciclesonide hydrofluoroalkane (HFA) nasal aerosol | Phase 3 | Perennial Allergic Rhinitis | - | - |
Pegzilarginase | Phase 3 | Arginase 1 Deficiency | - | - |
ChloraPrep | Phase 3 | Surgical Skin Preparation | - | - |
Ibuprofen | Phase 3 | Pain | - | - |
FK949E | Phase 3 | Bipolar Depression | - | - |
LEO 43204 gel | Phase 3 | Actinic Keratosis | - | - |
Buprenorphine transdermal system | Phase 3 | Pain | - | - |
Buprenorphine transdermal patch | Phase 3 | Osteoarthritis | - | - |
BPI-7711 | Phase 3 | NSCLC | - | - |
Toludesvenlafaxine Hydrochloride | Phase 3 | Generalized Anxiety Disorder | - | - |
ICP-488 Tablets | Phase 3 | Cutaneous Lupus Erythematosus (CLE) | - | - |
Relugolix | Phase 3 | Prostate Cancer | - | - |
Test - Bimatoprost Ophthalmic | Phase 3 | Glaucoma, Open-Angle | - | - |
Patiromer | Phase 3 | Hyperkalemia | - | - |
Argatroban | Phase 3 | Coronary Artery Disease | - | - |
Kinisoquin™ | Phase 3 | Venous Thromboembolism | - | - |
Teneligliptin/Canagliflozin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Lerotinib | Phase 3 | Esophageal Cancer | - | - |
Treatment and prophylaxis | Phase 3 | COVID-19 | - | - |
ferrous sulphate | Phase 3 | Anaemia | - | - |
Darbepoetin alfa | Phase 3 | Anemia; Non-dialysis Dependent Chronic Kidney Disease | - | - |
PA21 (tablet containing iron) | Phase 3 | Chronic Kidney Disease Requiring Chronic Dialysis | - | - |
LEO 80185 gel | Phase 3 | Psoriasis Vulgaris | - | - |
Relugolix Combination Tablet | Phase 3 | Uterine Fibroids | - | - |
MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®) | Phase 3 | Chronic Kidney Disease | - | - |
ciclesonide | Phase 3 | Perennial Allergic Rhinitis | - | - |
dasiglucagon | Phase 3 | Congenital Hyperinsulinism | - | - |
AMPH ER Tab | Phase 3 | ADHD | - | - |
TA-7284-Low | Phase 3 | Type 2 Diabetes Mellitus | - | - |
YM178 | Phase 3 | Urinary Bladder, Overactive | - | - |
tolterodine | Phase 3 | Urinary Bladder, Overactive | - | - |
Lonapegsomatropin | Phase 3 | Adult Growth Hormone Deficiency | - | - |
Certolizumab Pegol (CDP870) | Phase 3 | Crohn's Disease | - | - |
Ferinject ® (Ferric carboxymaltose) | Phase 3 | Chronic Heart Failure | - | - |
INZ-701 | Phase 3 | Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency | - | - |
Control Arm (Conventional Therapy) | Phase 3 | Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency | - | - |
Setidegrasib | Phase 3 | Non-small Cell Lung Cancer (NSCLC) | - | - |
hCRF [XERECEPT (corticorelin acetate injection)] | Phase 3 | Brain Edema | - | - |
Teneligliptin + Sulfonylurea | Phase 3 | Type 2 Diabetes Mellitus | - | - |
LY01005 | Phase 3 | Breast Cancer | - | - |
Daivobet® gel | Phase 3 | Psoriasis Vulgaris | - | - |
Azelaic acid foam (BAY39-6251) | Phase 3 | Papulopustular Rosacea | - | - |
Dasotraline | Phase 3 | Adult Attention Deficit Hyperactivity Disorder | - | - |
Ferric carboxymaltose | Phase 3 | Inflammatory Bowel Disease | - | - |
Pimecrolimus | Phase 3 | Atopic Dermatitis | - | - |
Alteplase | Phase 3 | Cerebral Infarction | - | - |
DPT-IPV-Hib | Phase 3 | Tetanus | - | - |
Asacol® | Phase 3 | Active Ulcerative Colitis | - | - |
Levalbuterol | Phase 3 | Asthma | - | - |
Delgocitinib | Phase 3 | Chronic Hand Eczema | - | - |
ingenol mebutate | Phase 3 | Actinic Keratosis | - | - |
Sodium zirconium cyclosilicate | Phase 3 | Hyperkalemia | - | - |
Rotigotine | Phase 3 | Idiopathic Parkinson's Disease | - | - |
adagloxad simolenin combined with OBI-821 | Phase 3 | Triple Negative Breast Cancer | - | - |
Extract from Hintonia latiflora bark | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Teneli/Teneli + pio | Phase 3 | Type 2 Diabetes Mellitus | - | - |
TOP1630 Ophthalmic Solution OU | Phase 3 | Dry Eye Syndrome | - | - |
Obicetrapib | Phase 3 | Atherosclerotic Cardiovascular Disease | - | - |
Levalbuterol HCl Inhalation Solution | Phase 3 | Reactive Airways Disease (RAD) | - | - |
vernakalant hydrochloride | Phase 3 | Atrial Fibrillation | - | - |
calcipotriol and betamethasone (LEO 80185 gel) | Phase 3 | Psoriasis Vulgaris | - | - |
SM-13496 | Phase 3 | Bipolar Depression | - | - |
LEO 90100 aerosol foam | Phase 3 | Psoriasis Vulgaris | - | - |
Probio-Tec® BG-VCap-6.5 | Phase 3 | Diarrhea | - | - |
Mirabegron | Phase 3 | Urinary Bladder, Overactive | - | - |
peficitinib | Phase 3 | Arthritis, Rheumatoid | - | - |
solifenacin succinate | Phase 3 | Lower Urinary Tract Symptoms | - | - |
APL-130277 | Phase 3 | Parkinson Disease | - | - |
Solifenacin Succinate Suspension | Phase 3 | Urinary Bladder, Overactive | - | - |
DFD06-Cream | Phase 3 | Chronic Stable Plaque Psoriasis | - | - |
Ingenol metabute | Phase 3 | Actinic Keratosis | - | - |
gilteritinib | Phase 3 | Acute Myeloid Leukemia (AML) | - | - |
Viltolarsen | Phase 3 | Duchenne Muscular Dystrophy | - | - |
Artesunate+Sulfamethoxypyrazine/pyrimethamin | Phase 3 | Schistosoma Haematobium | - | - |
ZuraPrep Clear Solution | Phase 3 | Surgical Skin Preparation | - | - |
Probiotic (Inersan) | Phase 3 | Chronic Periodontitis | - | - |
mesalazine | Phase 3 | Crohn's Disease | - | - |
Botulinum Toxin A - Open Label | Phase 3 | Glabellar Frown Lines | - | - |
LEO 90105 = calcipotriol + betamethasone dipropionate | Phase 3 | Psoriasis | - | - |
BBI608 | Phase 3 | Malignant Pleural Mesothelioma | - | - |
glepaglutide | Phase 3 | Short Bowel Syndrome | - | - |
Oxycodone/Naloxone controlled-release | Phase 3 | Low Back Pain | - | - |
Roxadustat | Phase 3 | Chronic Kidney Disease | - | - |
[F-18]Flornaptitril | Phase 3 | Alzheimer Disease | - | - |
LEO 90100 foam | Phase 3 | Psoriasis Vulgaris | - | - |
DSP-7888 Dosing Emulsion | Phase 3 | Glioblastoma | - | - |
Irinotecan hydrochloride liposome Injection | Phase 3 | Relapsed Small Cell Lung Cancer | - | - |
Levosert-20 | Phase 3 | Heavy Menstrual Bleeding | - | - |
Certolizumab pegol | Phase 3 | Crohn's Disease | - | - |
PLS240 | Phase 3 | Secondary Hyperparathyroidism | - | - |
Levocetirizine dihydrochloride | Phase 3 | Rhinitis | - | - |
Eicosapentanoic Acid (EPA) | Phase 3 | Familial Adenomatous Polyposis Coli | - | - |
Udenafil | Phase 3 | Single Ventricle Heart Disease After Fontan Surgery | - | - |
YM150 | Phase 3 | Atrial Fibrillation | - | - |
Vernakalant | Phase 3 | Atrial Fibrillation | - | - |
ASF1057 | Phase 3 | Seborrheic Dermatitis | - | - |
AJM300 | Phase 3 | Colitis, Ulcerative | - | - |
Exisulind | Phase 3 | Non-Small Cell Lung Cancer | - | - |
YM060 | Phase 3 | Diarrhea-predominant Irritable Bowel Syndrome | - | - |
LAM561 | Phase 3 | High-grade Glioma | - | - |
Linaprazan glurate | Phase 3 | GERD (Gastroesophageal Reflux Disease) | - | - |
Ciprodex® | Phase 3 | Acute Otitis Externa | - | - |
ASP1585 | Phase 3 | Chronic Kidney Disease | - | - |
LY03003(Rotigotine,extended-release microspheres) | Phase 3 | Parkinson Disease | - | - |
Trazodone | Phase 3 | Sleep Disorder | - | - |
Spesolimab | Phase 3 | Generalized Pustular Psoriasis | - | - |
s.c. injection | Phase 3 | Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma | - | - |
DSP-5423P | Phase 3 | Schizophrenia | - | - |
ciclesonide nasal aerosol | Phase 3 | Perennial Allergic Rhinitis | - | - |
Zirconium silicate (acute phase) | Phase 3 | Hyperkalemia | - | - |
1PC002 | Phase 3 | Hypercholesterolemia | - | - |
LY03005 extended-release tablet | Phase 3 | Major Depressive Disorder (MDD) | - | - |
APD421- Amisulpride for IV injection | Phase 3 | PONV | - | - |
House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae | Phase 3 | House Dust Mite Allergy | - | - |
Amisulpride Injection | Phase 3 | Nausea and Vomiting, Postoperative | - | - |
Cocaine Hydrochloride Nasal Solution | Phase 3 | ENT Disorder | - | - |
ipragliflozin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
C213 Microneedle System | Phase 3 | Cluster Headache | - | - |
Teneligliptin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
ASKB589 | Phase 3 | Gastroesophageal Junction Adenocarcinoma | - | - |
ORADUR®-Methylphenidate | Phase 3 | Attention Deficit Hyperactivity Disorder | - | - |
Delgocitinib cream | Phase 3 | Chronic Hand Eczema | - | - |
Levalbuterol HCl | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Vitamin D (Cholecalciferol) | Phase 3 | Prediabetes | - | - |
LEO43204 gel | Phase 3 | Actinic Keratosis | - | - |
TMZ | Phase 3 | Primary Glioblastoma | - | - |
DOXIL | Phase 3 | Ovarian Neoplasms | - | - |
LP-003 | Phase 3 | Chronic Spontaneous Urticaria | - | - |
Lipid emulsion without progesterone | Phase 3 | Brain Injuries | - | - |
MT-7117 Low Dose | Phase 3 | EPP | - | - |
metyrapone | Phase 3 | Cushing's Syndrome | - | - |
Remimazolam | Phase 3 | Pediatric ALL | - | - |
Peginterferon Alfa-2A | Phase 3 | Chronic Hepatitis, B Virus | - | - |
JS105 | Phase 3 | Breast Cancer | - | - |
ASP1941 | Phase 3 | Type 1 Diabetes Mellitus | - | - |
MCI-196 | Phase 3 | Type 2 Diabetes | - | - |
Another Phosphate binder (Sevelamer) | Phase 3 | Chronic Kidney Disease | - | - |
PEGASYS | Phase 3 | High Risk Polycythemia Vera | - | - |
Pegylated Lipoxomal Doxorubicin (PLD) | Phase 3 | Ovarian Cancer | - | - |
Arformoterol tartrate inhalation solution | Phase 3 | COPD | - | - |
Trabectedin | Phase 3 | Mesenchymal Chondrosarcoma | - | - |
Oxybutynin | Phase 3 | Urge Urinary Incontinence | - | - |
Doxorubicin | Phase 3 | Metastatic Sarcoma | - | - |
Ifosfamide | Phase 3 | Sarcoma | - | - |
DMB-3115 | Phase 3 | Moderate to Severe Chronic Plaque Psoriasis | - | - |
Dexamethasone | Phase 3 | Breast Neoplasms | - | - |
Irinotecan | Phase 3 | Advanced Solid Tumors | - | - |
Topotecan | Phase 3 | Relapsed Small Cell Lung Cancer | - | - |
Dacarbazine | Phase 3 | Advanced Liposarcoma or Leiomyosarcoma | - | - |
SP-01 (Granisetron Transdermal Delivery System) | Phase 3 | Chemotherapy-induced Nausea and Vomiting | - | - |
ketotifen fumarate | Phase 3 | Dermatitis | - | - |
BNP7787 | Phase 3 | Breast Neoplasms | - | - |
Cholecalciferol | Phase 3 | Vitamin D Deficiency | - | - |
Polyethylene Glycol-treated Human Immunoglobulin (VGIH) | Phase 3 | Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin | - | - |
PRC-063 oral capsules | Phase 3 | ADHD | - | - |
ICP-248 | Phase 3 | Hematologic Malignancies | - | - |
IB1001 | Phase 3 | Hemophilia B | - | - |
Drospirenone | Phase 3 | Contraception | - | - |
levalbuterol tartrate MDI | Phase 3 | Asthma | - | - |
Calcipotriol plus hydrocortisone ointment vehicle | Phase 3 | Psoriasis Vulgaris | - | - |
Lurasidone HCl | Phase 3 | Schizophrenia | - | - |
Pudexacianinium chloride | Phase 3 | Laparoscopic/Minimally Invasive Colorectal Surgery | - | - |
olmesartan medoxomil | Phase 3 | Essential Hypertension | - | - |
Dalbavancin administration | Phase 3 | Catheter Bacteremia | - | - |
SM-13496 (lurasidone HCl) | Phase 3 | Schizophrenia | - | - |
Pre-screening Phase | Phase 3 | Soil-Transmitted Helminths | - | - |
ON 01910.Na | Phase 3 | Myelodysplastic Syndrome | - | - |
Parcopa | Phase 3 | Parkinson's Disease | - | - |
CNTO 148 | Phase 3 | Rheumatoid Arthritis | - | - |
Esflurbiprofen Topical System (EFTS) | Phase 3 | Contusions | - | - |
DPT-IPV-Hib-High(Combined Vaccine) | Phase 3 | Immunization; Infection | - | - |
M207 Microneedle System | Phase 3 | Migraine | - | - |
XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght | Phase 3 | End Stage Renal Disease | - | - |
Ensifentrine | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Budesonide orodispersible | Phase 3 | Eosinophilic Esophagitis | - | - |
Levalbuterol tartrate HFA MDI | Phase 3 | Exercise-induced Bronchospasm | - | - |
Metformin ≥ | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Teysuno | Phase 3 | Colorectal Cancer | - | - |
Calcipotriol plus betamethasone | Phase 3 | Psoriasis Vulgaris | - | - |
DPT-IPV-Hib (Combined Vaccine) | Phase 3 | Immunization | - | - |
Inersan | Phase 3 | Chronic Periodontitis | - | - |
norUrsodeoxycholic Acid | Phase 3 | Primary Sclerosing Cholangitis | - | - |
Imiquimod cream + surgery | Phase 3 | Lentigo Maligna Melanoma (Head or Neck) | - | - |
ASP7374 | Phase 3 | Influenza | - | - |
zolbetuximab | Phase 3 | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | - | - |
Mitizodone Phosphate tablets | Phase 3 | Depressive Disorder, Major | - | - |
UB-851 | Phase 3 | Renal Anemia | - | - |
Daridorexant | Phase 3 | Insomnia Disorder | - | - |
Phlogenzym | Phase 3 | Thrombophlebitis Leg | - | - |
TA-7284 Low | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Lacosamide | Phase 3 | Painful Diabetic Neuropathy | - | - |
Levocetirizine | Phase 3 | Dermatitis, Atopic | - | - |
Tralokinumab + TCS | Phase 3 | Atopic Dermatitis | - | - |
Basimglurant | Phase 3 | Trigeminal Neuralgia | - | - |
Lurasidone initially rerandomized either to or at week 2 | Phase 3 | Schizophrenia | - | - |
1PC111 | Phase 3 | Primary Hypercholesterolemia | - | - |
Co-Arinate FDC | Phase 3 | Plasmodium Falciparum Malaria | - | - |
Oxypurinol | Phase 3 | Congestive Heart Failure | - | - |
Epanova | Phase 3 | Crohn's Disease | - | - |
Vernakalant Injection | Phase 3 | Atrial Fibrillation | - | - |
TransCon hGH | Phase 3 | Growth Hormone Deficiency, Pediatric | - | - |
olmesartan medoxomil oral tablets, hydrochlorothiazide oral tablets | Phase 3 | Essential Hypertension | - | - |
HEC585 | Phase 3 | Idiopathic Pulmonary Fibrosis | - | - |
Doxorubicin (DOX) | Phase 3 | Small-cell Lung Cancer | - | - |
ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System) | Phase 3 | Osteoarthritis | - | - |
Levonorgestrel | Phase 3 | Contraception | - | - |
Zilucoplan® | Phase 3 | Generalized Myasthenia Gravis (gMG) | - | - |
C21 | Phase 3 | Idiopathic Pulmonary Fibrosis | - | - |
MCI-9042 | Phase 3 | Cerebral Infarction | - | - |
PerioChip ® | Phase 3 | Generalized Adult Periodontitis | - | - |
MesoPher | Phase 3 | Mesothelioma | - | - |
CDP870 | Phase 3 | Rheumatoid Arthritis | - | - |
co-administration of aztreonam and nacubactam | Phase 3 | Complicated Urinary Tract Infection | - | - |
Teneli/Teneli + SU | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Broncho-Vaxom | Phase 3 | Atopic Dermatitis | - | - |
S-Caine™ Peel (lidocaine and tetracaine cream) | Phase 3 | Pain | - | - |
Dovobet ® ointment | Phase 3 | Psoriasis Vulgaris | - | - |
hu1418K322A + Temozolomide + Irinotecan | Phase 3 | High-Risk Neuroblastoma | - | - |
Brivaracetam | Phase 3 | Epilepsy | - | - |
Calcipotriene/betamethasone gel and ointment | Phase 3 | Psoriasis | - | - |
hCRF | Phase 3 | Brain Edema | - | - |
Arformoterol 25 ųg BID | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Oxybutynin Hydrochloride | Phase 3 | Spina Bifida | - | - |
Active Theramine and Active Naproxen | Phase 3 | Low Back Pain | - | - |
Combination antiviral therapy | Phase 3 | Primary Biliary Cirrhosis | - | - |
YM443 | Phase 3 | Dyspepsia | - | - |
ZuraPrep | Phase 3 | Surgical Site Infection | - | - |
Tryptophan | Phase 3 | Schizophrenia | - | - |
Abarelix | Phase 3 | Prostate Cancer | - | - |
Thioctic Acid | Phase 3 | Diabetic Polyneuropathy | - | - |
mesalamine granules | Phase 3 | Colitis, Ulcerative | - | - |
Vibegron | Phase 3 | Neurogenic Detrusor Overactivity | - | - |
Atenolol | Phase 3 | Essential Hypertension | - | - |
Caspofungin | Phase 3 | Candidiasis | - | - |
Icosapent Ethyl | Phase 3 | Liver Metastasis | - | - |
Ferinject (ferric carboxymaltose) | Phase 3 | Iron Deficiency | - | - |
[O-15]-Water PET Myocardial Perfusion Imaging (MPI) | Phase 3 | Coronary Artery Disease | - | - |
Test Product | Phase 3 | Bronchial Asthma | - | - |
LPRI424 (dienogest/ethinylestradiol) | Phase 3 | Contraception | - | - |
Tinzaparin | Phase 3 | Colorectal Cancer Metastatic | - | - |
MOB015B | Phase 3 | Distal Subungual Onychomycosis | - | - |
Salmeterol | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Epanova™ (Omega-3 Free Fatty Acids) | Phase 3 | Crohn's Disease | - | - |
Benzocaine Otic Solution | Phase 3 | Pain | - | - |
Use Phase (Ulipristal Acetate) | Phase 3 | Emergency Contraception | - | - |
Toctino | Phase 3 | Chronic Hand Eczema | - | - |
Hydrocodone bitartrate q24h film-coated tablets | Phase 3 | Chronic Low Back Pain | - | - |
co-administration of cefepime and nacubactam | Phase 3 | Complicated Urinary Tract Infection | - | - |
ASC30 tablets A1 | Phase 3 | Obesity | - | - |
Esmolol Hydrochloride | Phase 3 | Diabetic Foot Ulcer | - | - |
Aldara (Imiquimod) | Phase 3 | Actinic Keratosis | - | - |
levetiracetam (Keppra) | Phase 3 | Alcohol Dependence | - | - |
Luspatercept | Phase 3 | Myelodysplastic Syndromes | - | - |
PL2200 Aspirin Capsules | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Itopride | Phase 3 | Healthy Volunteers | - | - |
Asenapine | Phase 3 | Schizophrenia | - | - |
SPM 962 | Phase 3 | Parkinson Disease, Idiopathic | - | - |
Nifedipine | Phase 3 | Chronic Anal Fissure | - | - |
Chlorhexidine gluconate chip | Phase 3 | Peri-Implantitis | - | - |
Ursodeoxycholic acid | Phase 3 | Chronic Hepatitis C | - | - |
Lactulose | Phase 3 | Chronic Liver Disease | - | - |
ELGN-2112 | Phase 3 | Intestinal Malabsorption | - | - |
Diltiazem hydrochloride | Phase 3 | Chronic Anal Fissure | - | - |
Sevelamer carbonate | Phase 3 | Chronic Kidney Disease Requiring Chronic Dialysis | - | - |
approved egg-derived TIV | Phase 3 | Influenza | - | - |
nateglinide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Calcipotriol plus betamethasone dipropionate (LEO80185 gel) | Phase 3 | Psoriasis of Scalp | - | - |
Oxycodone HCl controlled-release tablets | Phase 3 | Pain | - | - |
Buagafuran capsules | Phase 3 | Generalized Anxiety Disorder | - | - |
ART-123 | Phase 3 | Severe Sepsis | - | - |
Qutenza (capsaicin) topical system | Phase 3 | Post Surgical Neuropathic Pain | - | - |
Azelastine Hydrochl./Fluticasone Prop | Phase 3 | Allergic Rhinitis | - | - |
K40a | Phase 3 | Seborrhoeic Dermatitis of the Scalp | - | - |
Prophylactic anticoagulation (INNOHEP®) | Phase 3 | Anemia | - | - |
subcutaneous apomorphine | Phase 3 | Motor OFF Episodes Associated With Parkinson's Disease | - | - |
CDB-2914 | Phase 3 | Emergency Contraception | - | - |
administration of Cimzia® | Phase 3 | Axial and Peripheral Spondyloarthritis | - | - |
KP-100LI | Phase 3 | Vocal Fold Scar | - | - |
FlutiForm 250/10 | Phase 3 | Asthma | - | - |
FK506 | Phase 3 | Keratoconjunctivitis | - | - |
Baker's yeast (Bio Chromium) | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
TRS01 | Phase 3 | Non-infectious Anterior Uveitis | - | - |
SYN023 | Phase 3 | Rabies | - | - |
MP-513 | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Relugolix Combination Therapy | Phase 3 | Contraception | - | - |
Ciclesonide HFA | Phase 3 | Seasonal Allergic Rhinitis | - | - |
Vitamin D | Phase 3 | Sarcopenia | - | - |
Tehalose 30gr | Phase 3 | Muscular Dystrophy, Oculopharyngeal (OPMD) | - | - |
TA-650 | Phase 3 | Crohn's Disease | - | - |
ZuraPrep with IPA | Phase 3 | Surgical Site Infection | - | - |
Budesonide granules | Phase 3 | Incomplete Microscopic Colitis | - | - |
Linsitinib | Phase 2 | Relapsed Ewing Sarcoma | - | - |
Moxifloxacin | Phase 2 | Parkinson's Disease | - | - |
Standard arm: Trabectedin in monotherapy | Phase 2 | Advanced Soft Tissue Sarcoma | - | - |
gemcitabine + docetaxel | Phase 2 | Leiomyosarcoma | - | - |
LEO90100 cutaneous spray, ointment | Phase 2 | Psoriasis Vulgaris | - | - |
Sepranolone injection low dose | Phase 2 | Menstrual Migraine | - | - |
Engineered cartilage graft (N-TEC) | Phase 2 | Patellofemoral Osteoarthritis | - | - |
Fluticasone Propionate | Phase 2 | COPD | - | - |
No Intervention: Observational Cohort | Phase 2 | Leiomyosarcoma of Ovary | - | - |
Levalbuterol HFA MDI followed by Racemic albuterol HFA MDI | Phase 2 | Asthma | - | - |
ZPL-3893787 | Phase 2 | Atopic Dermatitis | - | - |
Budesonide plus Prevacid | Phase 2 | Eosinophilic Esophagitis | - | - |
AG-73305 | Phase 2 | Diabetic Macular Edema | - | - |
Racemic formoterol | Phase 2 | COPD | - | - |
miravirsen | Phase 2 | Hepatitis C | - | - |
CPL500036 - low dose | Phase 2 | Schizophrenia | - | - |
AK102 | Phase 2 | Hypercholesterolemia | - | - |
Clifutinib Besylate | Phase 2 | Acute Myeloid Leukemia, Adult | - | - |
Zuberitamab | Phase 2 | Marginal Zone Lymphoma(MZL) | - | - |
Calcium Dobesilate | Phase 2 | COVID-19 Virus Disease | - | - |
HEC110114 Tablet | Phase 2 | Chronic Hepatitis C | - | - |
Biphasic Remogliflozin Etabonate | Phase 2 | Type 2 Diabetes Mellitus | - | - |
ASF 1096 cream applied | Phase 2 | Discoid Lupus Erythematosus | - | - |
ASP8062 | Phase 2 | Alcohol Use Disorder | - | - |
YP-P10 Ophthalmic | Phase 2 | Dry Eye | - | - |
lidocaine and tetracaine | Phase 2 | Postherpetic Neuralgia | - | - |
Interferon-gamma (IFN-γ) | Phase 2 | Breast Cancer | - | - |
TG-1000 | Phase 2 | Influenza Virus Infection | - | - |
Estriol | Phase 2 | Vaginal Atrophy | - | - |
BBI503 | Phase 2 | Hepatocellular Carcinoma | - | - |
ASP1707 | Phase 2 | Rheumatoid Arthritis | - | - |
SPP635 (drug) | Phase 2 | Hypertension | - | - |
Fosaprepitant | Phase 2 | CINV | - | - |
OBI-833/OBI-821 | Phase 2 | Non-small Cell Lung Cancer | - | - |
Ciprofloxacin Ear Drops | Phase 2 | Otitis Externa | - | - |
PEG-hirudin | Phase 2 | Chronic Kidney Failure | - | - |
Recombinant Influenza HA Vaccine (H5N1) | Phase 2 | Influenza | - | - |
YY-351 | Phase 2 | Diabetes | - | - |
CAL101 | Phase 2 | Idiopathic Pulmonary Fibrosis | - | - |
APG-115 | Phase 2 | Liposarcoma | - | - |
A-dopamine | Phase 2 | Parkinson Disease | - | - |
Dexamethasone or equivalent steroid | Phase 2 | Neoplasm Metastases | - | - |
Phase 2: Trabectedin | Phase 2 | Soft-tissue Sarcomas | - | - |
Nemonoxacin | Phase 2 | Pneumonia | - | - |
Cis-UCA emulsion | Phase 2 | Atopic Dermatitis | - | - |
Phase 2: Cyclophosphamide | Phase 2 | Soft-tissue Sarcomas | - | - |
Experimental arm: Trabectedin + Olaparib | Phase 2 | Advanced Soft Tissue Sarcoma | - | - |
Z650 | Phase 2 | Esophageal Squamous Cell Carcinoma | - | - |
Cerebral Dopamine Neurotrophic Factor | Phase 2 | Parkinson Disease | - | - |
ZR-02-01 Fentanyl Transdermal Matrix Patch | Phase 2 | Pain | - | - |
ART6043 | Phase 2 | Advanced Solid Tumor | - | - |
ZED1227 + SIGE | Phase 2 | Celiac Disease | - | - |
GamTBvac vaccine | Phase 2 | Healthy | - | - |
Enzomenib | Phase 2 | Leukemia, Myeloid, Acute | - | - |
Phase 1: Cyclophosphamide | Phase 2 | Soft-tissue Sarcomas | - | - |
tacrolimus modified release (MR) | Phase 2 | Liver Transplantation | - | - |
Aromatase Inhibitors | Phase 2 | Breast Neoplasm | - | - |
APHD-012P | Phase 2 | Obese | - | - |
LP-003 dose 1 | Phase 2 | Seasonal Allergic Rhinitis | - | - |
Cobiprostone | Phase 2 | NSAID-induced Gastroduodenal Injury | - | - |
Ciprofloxacin Foam Otic Cipro | Phase 2 | Otitis Externa | - | - |
Liposomeal curcumin | Phase 2 | Patients w/Advanced Cancer That Failed Std of Care Therapy | - | - |
SPH3127 tablet Dose 1 | Phase 2 | Hypertension,Essential | - | - |
Dispensing Codivir® | Phase 2 | HIV | - | - |
SAP-001 | Phase 2 | Gout | - | - |
Oral isotretinoin | Phase 2 | Actinic Keratosis | - | - |
Act-HIB® | Phase 2 | Healthy | - | - |
Sertaconazole | Phase 2 | Skin Alterations Associated With Atopic Dermatitis | - | - |
EMP16-02 orlistat/acarbose | Phase 2 | Overweight or Obesity | - | - |
Nifedipine coated suppositories | Phase 2 | Chronic Anal Fissure | - | - |
AC-3933 | Phase 2 | Alzheimer's Disease | - | - |
Picato | Phase 2 | Anogenital Warts | - | - |
CT053PTSA | Phase 2 | Non-small Cell Lung Cancer | - | - |
Amikacin fosfomycin inhalation solution | Phase 2 | Pneumonia, Bacterial | - | - |
Temozolomide in both arms | Phase 2 | Glioblastoma | - | - |
Heated lidocaine/tetracaine patch | Phase 2 | Myofascial Pain Syndromes | - | - |
ACP-196 (acalabrutinib) | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
PolyCore (Polydextrin, L-Carnitine, D-xylitol) | Phase 2 | Congestive Heart Failure | - | - |
MT-3921 | Phase 2 | Spinal Cord Injury | - | - |
MP-424 (Telaprevir) | Phase 2 | Hepatitis C | - | - |
Saccharomyces cerevisiae | Phase 2 | Irritable Bowel Syndrome | - | - |
NRC-2694-A | Phase 2 | Carcinoma | - | - |
NS-050/NCNP-03 | Phase 2 | Duchenne Muscular Dystrophy | - | - |
CPL409116 | Phase 2 | Rheumatoid Arthritis | - | - |
OCZ103-OS [pentamidine bis(2-hydroxyethanesulfonate)], mFOLFOX6 or FOLFIRI | Phase 2 | Colorectal Cancer | - | - |
MCC-257 | Phase 2 | Diabetic Polyneuropathy | - | - |
Bupivacaine | Phase 2 | Mucositis | - | - |
once daily for two consecutive days (Picato) | Phase 2 | Actinic Keratosis | - | - |
Donepezil Transdermal | Phase 2 | Irritation/Irritant | - | - |
cefepime and enmetazobactam combination | Phase 2 | Complicated Urinary Tract Infection | - | - |
MT-4561 | Phase 2 | Head and Neck Squamous Cell Carcinoma (HNSCC) | - | - |
MT-2990 | Phase 2 | Endometrial Related Pain | - | - |
intravitreal injection of KH902 | Phase 2 | Neovascular Age-related Macular Degeneration | - | - |
JTR-161 | Phase 2 | Acute Ischemic Stroke | - | - |
ILT101 | Phase 2 | Bipolar Depression | - | - |
Chitosan- N- Acetylcysteine eye drops | Phase 2 | Dry Eye Syndrome | - | - |
rhIL-2 | Phase 2 | Type 1 Diabetes | - | - |
Photofrin | Phase 2 | Superficial Bladder Cancer | - | - |
Pegylated Liposomal Doxorubicine | Phase 2 | Glioblastoma | - | - |
PA21 (iron) | Phase 2 | Chronic Kidney Disease | - | - |
Xeomin | Phase 2 | Cerebral Palsy | - | - |
Polyphenon E (EGCG) | Phase 2 | Prostate Cancer | - | - |
Nicardipine | Phase 2 | Aneurysmal Subarachnoid Hemorrhage | - | - |
Acetaminophen and Ibuprofen | Phase 2 | Stomach Neoplasms | - | - |
FK778 | Phase 2 | Liver Transplantation | - | - |
V116517 50-mg tablets | Phase 2 | Postherpetic Neuralgia | - | - |
dexfadrostat phosphate | Phase 2 | Primary Aldosteronism | - | - |
PHP-201 ophthalmic | Phase 2 | Normal Tension Glaucoma | - | - |
CP-4055 | Phase 2 | Malignant Melanoma | - | - |
LAT8881 | Phase 2 | Acute Migraine | - | - |
E6011 | Phase 2 | Crohn's Disease | - | - |
LEO 138559 | Phase 2 | Atopic Dermatitis | - | - |
MT-4666 | Phase 2 | Alzheimer's Disease | - | - |
V120083 | Phase 2 | Osteo Arthritis Knee | - | - |
TSX-002 | Phase 2 | Hypogonadism | - | - |
OC-01 (varenicline) nasal spray | Phase 2 | Dry Eye Disease | - | - |
VNX001 | Phase 2 | Interstitial Cystitis | - | - |
NS-065/NCNP-01 | Phase 2 | Duchenne Muscular Dystrophy | - | - |
Levalbuterol HFA MDI | Phase 2 | Asthma | - | - |
JTT-851 | Phase 2 | Type 2 Diabetes Mellitus | - | - |
ICP-192 | Phase 2 | Intrahepatic Cholangiocarcinoma (ICC) | - | - |
VVD-101 | Phase 2 | Delayed Alcohol Induced Headache | - | - |
NTRX-07 | Phase 2 | Alzheimer Disease | - | - |
Pudafensine | Phase 2 | Vulvodynia | - | - |
Interleukin 2 | Phase 2 | Rheumatoid Arthritis | - | - |
PD solution containing glucose | Phase 2 | End Stage Renal Disease | - | - |
HEC169096 | Phase 2 | Advanced Solid Tumor | - | - |
LEO 43204 | Phase 2 | Actinic Keratosis | - | - |
LEO 29102 cream | Phase 2 | Psoriasis Vulgaris | - | - |
APHD-012 | Phase 2 | Obese With Comorbidities | - | - |
Alintegimod | Phase 2 | Advanced Cancer | - | - |
PA101 | Phase 2 | Refractory Chronic Cough | - | - |
LUM-201 | Phase 2 | Growth Hormone Deficiency | - | - |
collagenase | Phase 2 | Chronic Coronary Total Occlusions | - | - |
MCC-135 | Phase 2 | Myocardial Infarction | - | - |
Haemophilus b conjugate vaccine diphteria CRM197 protein conjugate)-Low + DPT-IPV | Phase 2 | Haemophilus Influenza Type b | - | - |
Saquinavir | Phase 2 | IDV Associated Nephrotoxicity | - | - |
NOX-H94 | Phase 2 | Anemia of Chronic Disease | - | - |
Daivonex cream | Phase 2 | Psoriasis | - | - |
JYP0015 | Phase 2 | Solid Tumor | - | - |
ET 743 | Phase 2 | Prostate Cancer | - | - |
BTA-C585 oral capsule | Phase 2 | Respiratory Syncytial Virus (RSV) Infection | - | - |
Sunobinop | Phase 2 | Alcohol Use Disorder | - | - |
MT-2111 | Phase 2 | Diffuse Large B-Cell Lymphoma | - | - |
LP0113 aerosol spray | Phase 2 | Skin and Connective Tissue Diseases | - | - |
NS-229 | Phase 2 | Eosinophilic Granulomatosis With Polyangiitis | - | - |
APG-2575 | Phase 2 | SLE | - | - |
LOAd703 | Phase 2 | Pancreatic Adenocarcinoma | - | - |
OBI-902 | Phase 2 | Advanced Solid Tumor | - | - |
X0002 Spray | Phase 2 | KNEE OSTEOARTHRITIS | - | - |
Betamethasone plus calcipotriol | Phase 2 | Psoriasis Vulgaris | - | - |
Tacrolimus | Phase 2 | Dermatitis, Atopic | - | - |
VentaProst (inhaled epoprostenol delivered via a dedicated delivery system) | Phase 2 | COVID-19 | - | - |
NT-KO-003 | Phase 2 | Relapsing Remitting Multiple Sclerosis | - | - |
XEN-D0501 | Phase 2 | Efficacy | - | - |
ONO-4641 | Phase 2 | Multiple Sclerosis | - | - |
ACP-196 | Phase 2 | Metastatic Pancreatic Cancer | - | - |
FP187 | Phase 2 | Plaque Psoriasis | - | - |
PRI-724 | Phase 2 | Acute Myeloid Leukemia | - | - |
JTT-302 | Phase 2 | Dyslipidemia | - | - |
Levosimendan | Phase 2 | Transient Ischemic Attack | - | - |
Formatris | Phase 2 | Asthma | - | - |
CIN-102 | Phase 2 | Idiopathic Gastroparesis | - | - |
CPL500036 - high dose | Phase 2 | Parkinson Disease | - | - |
Esketamine DPI - low dose | Phase 2 | Bipolar Depression | - | - |
Cannabisextrakt Avextra ösung | Phase 2 | Medical Oncology | - | - |
TD1414 | Phase 2 | Impetigo | - | - |
ODM-201 | Phase 2 | Prostate Cancer | - | - |
CyCol™ | Phase 2 | Mild to Moderate Ulcerative Colitis | - | - |
Phentolamine Mesylate Ophthalmic | Phase 2 | Mydriasis | - | - |
Sepranolone (UC1010) low dose | Phase 2 | Premenstrual Dysphoric Disorder | - | - |
ZED1227 | Phase 2 | NAFLD | - | - |
QHRD106 Injection (Low-dose group) | Phase 2 | Acute Ischemic Stroke | - | - |
NS-018 | Phase 2 | Primary Myelofibrosis | - | - |
SKB264 | Phase 2 | Non-small Cell Lung Cancer | - | - |
OPT-822/OPT-821 | Phase 2 | Metastatic Breast Cancer | - | - |
STP938 | Phase 2 | Lymphoma, B-Cell | - | - |
Olaptesed pegol - Monotherapy | Phase 2 | Metastatic Colorectal Cancer | - | - |
DAG181 | Phase 2 | Chronic HCV Infection | - | - |
Dexamethasone Iontophoretic Patch (low dose) | Phase 2 | Lateral Epicondylitis | - | - |
Sepranolone | Phase 2 | Tourette Syndrome | - | - |
JTE-051 | Phase 2 | Rheumatoid Arthritis | - | - |
recAP | Phase 2 | Acute Kidney Injury | - | - |
T3011 | Phase 2 | Solid Tumor | - | - |
WD-890 tablet | Phase 2 | Brief Description of Focus of Study | - | - |
MT-1303-Low | Phase 2 | Plaque Psoriasis | - | - |
MP-435(dose1) + Methotrexate | Phase 2 | Rheumatoid Arthritis | - | - |
Cromoglicate | Phase 2 | Psoriasis | - | - |
APD405 | Phase 2 | Postoperative Nausea and Vomiting | - | - |
Cultured Thymus Tissue for Implantation (CTTI) | Phase 2 | DiGeorge Anomaly | - | - |
K201 | Phase 2 | Atopic Dermatitis | - | - |
IDP-121 | Phase 2 | Multiple Myeloma (MM) | - | - |
SMP-986 | Phase 2 | Overactive Bladder Syndrome (OABS) | - | - |
AeroFact | Phase 2 | Respiratory Distress Syndrome in Premature Infant | - | - |
Minoxidil Topical | Phase 2 | Alopecia, Androgenetic | - | - |
TSD-001 | Phase 2 | Bladder Cancer Cell Transitional | - | - |
MP-513 Lowest Dose and Metformin | Phase 2 | Type 2 Diabetes Mellitus | - | - |
EP0031 | Phase 2 | NSCLC | - | - |
ME3183 | Phase 2 | Plaque Psoriasis | - | - |
OSI-211 (Liposomal Lurtotecan) | Phase 2 | Ovarian Neoplasms | - | - |
Isoquercetin | Phase 2 | Sickle Cell Disease | - | - |
Cultured Thymus Tissue Implantation (CTTI) | Phase 2 | DiGeorge Anomaly | - | - |
Racemic Albuterol followed by levalbuterol HFA MDI | Phase 2 | Asthma | - | - |
12 cm2 - 2 Active DMTS Patches | Phase 2 | Agitation | - | - |
Donor lymphocyte preparation depleted of functional host alloreactive T-cells (ATIR) | Phase 2 | Hematologic Diseases | - | - |
MKP10241 | Phase 2 | Type 2 Diabetes Mellitus (T2DM) | - | - |
JM-010 group A | Phase 2 | Dyskinesias | - | - |
MT-7117 | Phase 2 | Diffuse Cutaneous Systemic Sclerosis | - | - |
ICP-322 | Phase 2 | Prurigo Nodularis (PN) | - | - |
AP31969 | Phase 2 | Atrial Fibrillation (AF) | - | - |
Ilofotase alfa | Phase 2 | Open Heart Surgery | - | - |
AD981 | Phase 2 | Obesity Hypoventilation Syndrome (OHS) | - | - |
SMP3124LP | Phase 2 | Solid Tumor | - | - |
GS-248 | Phase 2 | Systemic Sclerosis | - | - |
AP09004 | Phase 2 | Parkinson's Disease | - | - |
LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel) | Phase 2 | Scalp Psoriasis | - | - |
CDB-2914 (ulipristal acetate) | Phase 2 | Contraception | - | - |
LP-003 Dose 1 (Single) | Phase 2 | Allergic Diseases | - | - |
Methotrexate (MTX) | Phase 2 | Rheumatoid Arthritis | - | - |
ACD440 | Phase 2 | Peripheral Neuropathic Pain | - | - |
OBI-992 | Phase 2 | Advanced Solid Tumor | - | - |
SPRC-AB01 | Phase 2 | Chronic Sinusitis | - | - |
LEO 90105 | Phase 2 | Psoriasis Vulgaris | - | - |
unoprostone isopropyl | Phase 2 | Dry Age-related Macular Degeneration | - | - |
TimoD implant | Phase 2 | Glaucoma | - | - |
OTP-01 | Phase 2 | Advanced Solid Tumors | - | - |
HEC585 dose A | Phase 2 | Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF) | - | - |
JTT-861 Capsules | Phase 2 | Chronic Heart Failure | - | - |
LEO 80185 (Xamiol® gel/Taclonex® Scalp topical suspension) | Phase 2 | Psoriasis Vulgaris | - | - |
Orelabrutinib (ICP-022) | Phase 2 | Part 1:r/r B-cell Malignancies | - | - |
JYP0061 | Phase 2 | Neuromyelitis Optica Spectrum Disorders | - | - |
DFD-07 Cream | Phase 2 | Actinic Keratosis | - | - |
PDC*lung01 | Phase 2 | Non Small Cell Lung Cancer | - | - |
ACP-319 | Phase 2 | Non-Hodgkins Lymphoma | - | - |
LUT014 Gel | Phase 2 | Radiation Dermatitis | - | - |
N17350 | Phase 2 | Neoplasms, Solid Tumor | - | - |
GIC-1001 | Phase 2 | Pain | - | - |
Cabaletta | Phase 2 | Oculopharyngeal Muscular Dystrophy | - | - |
Pirfenidone with MODD | Phase 2 | Diabetic Foot Ulcer | - | - |
MT-3995 Low | Phase 2 | Diabetic Nephropathy | - | - |
Ecopipam | Phase 2 | Tourette's Syndrome | - | - |
AP1189 | Phase 2 | Rheumatoid Arthritis | - | - |
IZN-6NVS Cream | Phase 2 | Atrophic Vaginitis | - | - |
TRS01 eye drops | Phase 2 | Non-infectious Anterior Uveitis | - | - |
LEO 152020 tablet | Phase 2 | Atopic Dermatitis | - | - |
Brimonidine tartrate Gel | Phase 2 | EGFR Inhibitor-associated Rash | - | - |
Cariprazine Depot | Phase 2 | Schizophrenia | - | - |
SG Depot | Phase 2 | Diabete Type 2 | - | - |
ILT-101 | Phase 2 | Systemic Lupus Erythematosus | - | - |
PL2200 | Phase 2 | Gastroduodenal Ulceration | - | - |
AP30663 | Phase 2 | Atrial Fibrillation | - | - |
LEO 124249 | Phase 2 | Alopecia Areata | - | - |
MT-1303 | Phase 2 | Crohn's Disease | - | - |
APH-012P | Phase 2 | PreDiabetes | - | - |
JTT-705 and pravastatin | Phase 2 | Type II Hyperlipidemia | - | - |
LEV102 | Phase 2 | Acquired Blepharoptosis | - | - |
Vonafexor | Phase 2 | Non-alcoholic Steatohepatitis | - | - |
SPP635 | Phase 2 | Hypertension | - | - |
RPh201, botanical drug product | Phase 2 | Healthy Volunteers | - | - |
IZN-6D4 Gel | Phase 2 | Diabetic Foot Ulcer | - | - |
CVXL-0107 | Phase 2 | Idiopathic Parkinson Disease | - | - |
MT-3995 | Phase 2 | NASH | - | - |
AC102 gel | Phase 2 | Hearing Loss, Sensorineural | - | - |
Mesalamine Oral Product | Phase 2 | Eosinophilic Esophagitis | - | - |
Amphetamine | Phase 2 | ADHD | - | - |
TYNADOTE | Phase 2 | Hepatitis | - | - |
ulipristal acetate | Phase 2 | Leiomyoma | - | - |
Acalabrutinib (ACP-196) | Phase 2 | Waldenström Macroglobulinemia (WM) | - | - |
QR-333 | Phase 2 | Diabetic Neuropathy | - | - |
Acalabrutinib (Arm A) | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
EYP001a | Phase 2 | Hepatitis B, Chronic | - | - |
Ingenol mebutate gel | Phase 2 | Actinic Keratosis | - | - |
ATIR101 | Phase 2 | Acute Myeloid Leukemia | - | - |
Treatment A: Azelastine hydrochloride nasal spray (Azelair) | Phase 2 | Seasonal Allergic Rhinitis | - | - |
ASC30 tablets | Phase 2 | T2DM (Type 2 Diabetes Mellitus) | - | - |
Ga-68 P16-093 PET/CT scan | Phase 2 | Prostate Cancer Recurrent | - | - |
Inhaled Aviptadil | Phase 2 | Covid19 | - | - |
AP611074 | Phase 2 | Anogenital Warts | - | - |
ASKG915 | Phase 2 | Advanced Solid Tumors | - | - |
NanoLithium® NP03 | Phase 2 | Alzheimer's Disease | - | - |
Botulinum toxin A "BoNT/A-DP" | Phase 2 | Frown Lines | - | - |
Delgocitinib cream vehicle | Phase 2 | Frontal Fibrosing Alopecia | - | - |
Naronapride | Phase 2 | Gastroparesis | - | - |
rigosertib | Phase 2 | Myelodysplastic Syndrome | - | - |
PP-001 | Phase 2 | Non-infectious Uveitis | - | - |
ONO-6950 | Phase 2 | Asthma | - | - |
EP0042 | Phase 2 | Acute Myeloid Leukemia | - | - |
BPI-7711 Capsule | Phase 2 | Non-small Cell Lung Cancer | - | - |
Oxymetazoline gel | Phase 2 | Fecal Incontinence | - | - |
ART0380 | Phase 2 | Advanced Cancer | - | - |
Daivobet® gel applied then removed after 10 minutes (+/- 2 minutes) | Phase 2 | Psoriasis Vulgaris | - | - |
LEO43204 | Phase 2 | Acne Vulgaris | - | - |
decitabine in combination with genistein | Phase 2 | Non Small Cell Lung Cancer | - | - |
HEC96719 | Phase 2 | Non-Alcoholic Steatohepatitis | - | - |
Pactimibe | Phase 2 | Atherosclerosis | - | - |
Mycograb, Docetaxel | Phase 2 | Cancer of the Breast | - | - |
LY01021 | Phase 2 | Assisted Reproduction | - | - |
ROSE-010 | Phase 2 | Obesity; Overweight | - | - |
Lactobacillus gasseri BGP345A | Phase 2 | Opioid-Induced Constipation | - | - |
ASC42 | Phase 2 | Primary Biliary Cholangitis | - | - |
LEO 124249 ointment | Phase 2 | Chronic Hand Eczema | - | - |
LTX-109 | Phase 2 | Nasal Decolonization of Staphylococcus Aureus | - | - |
avacincaptad pegol | Phase 2 | Stargardt's Macular Dystrophy | - | - |
L-carnitine | Phase 2 | End-Stage Renal Disease | - | - |
HL-085 | Phase 2 | Melanoma | - | - |
ASP8825 | Phase 2 | Restless Legs Syndrome | - | - |
MT-3995 High | Phase 2 | Diabetic Nephropathy | - | - |
human lactoferrin peptide 1-11 | Phase 2 | Hematopoietic Stem Cell Transplantation | - | - |
MT-1303-Middle | Phase 2 | Relapsing-remitting Multiple Sclerosis | - | - |
XEN-D0501,/tablet | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
JTT-705 and simvastatin | Phase 2 | Dyslipidemia | - | - |
PA101B | Phase 2 | Uremic Pruritus | - | - |
NP137 | Phase 2 | Endometrial Carcinoma | - | - |
RTV | Phase 2 | Chronic Hepatitis B | - | - |
Ciprodex Otic Suspension | Phase 2 | Otitis Externa | - | - |
C-82 Topical | Phase 2 | Systemic Scleroderma | - | - |
SP-02L (darinaparsin for injection) | Phase 2 | Peripheral T-Cell Lymphoma | - | - |
STC-1010 + IS regimen + SOC therapy | Phase 2 | Unresectable Metastatic Colorectal Cancer | - | - |
Aprepitant | Phase 2 | Pruritus | - | - |
SEP-225289 | Phase 2 | Adult Attention Deficit Hyperactivity Disorder | - | - |
ASF 1096 | Phase 2 | Discoid Lupus Erythematosus | - | - |
ASP3291 | Phase 2 | Ulcerative Colitis | - | - |
GM102 | Phase 2 | Colorectal Cancer | - | - |
Covidir injections | Phase 2 | COVID-19 | - | - |
Diacerein | Phase 2 | Complications of Diabetes Mellitus | - | - |
X842 | Phase 2 | Erosive Esophagitis | - | - |
SPC2996 | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
MT-1303-High | Phase 2 | Relapsing-remitting Multiple Sclerosis | - | - |
ASP8232 | Phase 2 | Healthy Subjects | - | - |
GRT6005 | Phase 2 | Diabetic Polyneuropathy | - | - |
Pradigastat | Phase 2 | Functional Constipation | - | - |
UMN-0501 | Phase 2 | Influenza | - | - |
Elacytarabine plus idarubicin | Phase 2 | Acute Myeloid Leukemia | - | - |
EP0057 | Phase 2 | Ovarian Cancer | - | - |
ONO-2952 | Phase 2 | Irritable Bowel Syndrome (IBS) | - | - |
JTT-705 and atorvastatin | Phase 2 | Dyslipidemia | - | - |
Alkaline Phosphatase | Phase 2 | Sepsis | - | - |
Azelaic acid | Phase 2 | Papulopustular Rosacea | - | - |
Ursodesoxycholic acid | Phase 2 | Serum Levels of ALAT Transaminases | - | - |
SEP-4199 | Phase 2 | Depressive Episode | - | - |
Rifalazil 25 milligram | Phase 2 | Chlamydia Trachomatis Infection | - | - |
YM155 | Phase 2 | Melanoma | - | - |
ICP-022 | Phase 2 | Waldenstrom's Macroglobulinemia Recurrent | - | - |
OSI-906 | Phase 2 | Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy | - | - |
Triamcinolone Acetonide (TAC) DuraPeel | Phase 2 | Hand Dermatoses | - | - |
ProTrans | Phase 2 | Type1diabetes | - | - |
ASP3652 | Phase 2 | Cystitis, Interstitial | - | - |
Naproxen | Phase 2 | Healthy Volunteers | - | - |
VDA-1102 | Phase 2 | Actinic Keratosis | - | - |
Norgestrel | Phase 2 | Contraception | - | - |
MT-3995 Middle | Phase 2 | Diabetic Nephropathy | - | - |
LEO 19123 Cream (calcipotriol plus LEO 80122) | Phase 2 | Psoriasis Vulgaris | - | - |
TL-895 | Phase 2 | Myelofibrosis | - | - |
ME-015 (Suplatast Tosilate) | Phase 2 | Idiopathic Pulmonary Fibrosis | - | - |
Chlorhexidine | Phase 2 | Peri-implantitis | - | - |
NOE-115 | Phase 2 | Menopause Syndrome | - | - |
SXR1096 cream | Phase 2 | Netherton Syndrome | - | - |
Vipoglanstat | Phase 2 | Endometriosis | - | - |
Depigoid Phleum | Phase 2 | Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma | - | - |
ODM-212 | Phase 2 | Solid Tumours | - | - |
PM01183 | Phase 2 | Breast Cancer | - | - |
Zalypsis | Phase 2 | Ewing's Sarcoma | - | - |
VX-745 | Phase 2 | Alzheimer's Disease | - | - |
APD515 | Phase 2 | Xerostomia in Advanced Cancer Patients | - | - |
Aplidin® | Phase 2 | Leukemia | - | - |
Calcipotriol plus betamethasone dipropionate (LEO 80185) gel | Phase 2 | Psoriasis Vulgaris | - | - |
APLIDIN (plitidepsin) | Phase 2 | Myelofibrosis | - | - |
Transdermal Ketoprofen Patch with CHADD | Phase 2 | Pain | - | - |
TL-925 | Phase 2 | Allergic Conjunctivitis | - | - |
PM54 | Phase 2 | Advanced Malignancies | - | - |
EXE-346 | Phase 2 | Ileal Pouch | - | - |
PM060184 | Phase 2 | Advanced Colorectal Cancer | - | - |
Flurbiprofen Tape (Arm 2) | Phase 2 | Chronic Low Back Pain | - | - |
IV CP-4126 | Phase 2 | Advanced Adenocarcinoma of Pancreas | - | - |
BPI-1178 | Phase 2 | Advanced Solid Tumor | - | - |
DFD06 Cream | Phase 2 | Psoriasis | - | - |
GRASPA | Phase 2 | Acute Lymphoblastic Leukemia | - | - |
VIOKASE 16 | Phase 2 | Exocrine Pancreatic Insufficiency | - | - |
OCZ103-OS | Phase 2 | Non-small Cell Lung Cancer | - | - |
CP-461 | Phase 2 | Prostate Cancer | - | - |
GA Depot | Phase 2 | Multiple Sclerosis | - | - |
Fosmidomycin and Clindamycin co-administration | Phase 2 | Malaria | - | - |
Phenyephrine | Phase 2 | Incontinence | - | - |
pentamidine | Phase 2 | Colorectal Cancer | - | - |
Calcipotriol and LEO80122 (LEO19123 cream) | Phase 2 | Hand Eczema | - | - |
ONO-5129 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
VA2914 | Phase 2 | Contraception | - | - |
TOP-N53 | Phase 2 | Digital Ulcers in Systemic Sclerosis | - | - |
RPL554 | Phase 2 | Asthma | - | - |
MOB015 | Phase 2 | Onychomycosis | - | - |
LP-005 Injection | Phase 2 | PNH - Paroxysmal Nocturnal Hemoglobinuria | - | - |
ASP7373 | Phase 2 | Healthy | - | - |
ASC41 | Phase 2 | Non-alcoholic Fatty Liver Disease | - | - |
Orelabrutinib (Low Dose) | Phase 2 | Systemic Lupus Erythematosus, SLE | - | - |
ONO-2333Ms Experimental 2 | Phase 2 | Major Depressive Disorder | - | - |
DMTS | Phase 2 | Pain, Postoperative | - | - |
BGP-014 | Phase 2 | Ulcerative Colitis | - | - |
Flurbiprofen | Phase 2 | Periodontitis | - | - |
LEO 29102 | Phase 2 | Atopic Dermatitis | - | - |
CM355 | Phase 2 | Hematoma | - | - |
LPM3770164 | Phase 2 | Tardive Dyskinesia (TD) | - | - |
ONO-1101 | Phase 2 | Postoperative Supraventricular Tachyarrythmia | - | - |
Zirconium silicate (ZS) | Phase 2 | Hyperkalemia | - | - |
Theralux extracorporeal photochemotherapy | Phase 2 | Graft vs Host Disease | - | - |
ICP-723 | Phase 2 | Solid Tumors | - | - |
KAND567 | Phase 2 | Epithelial Ovarian Cancer | - | - |
Vernakalant (oral) | Phase 2 | Atrial Fibrillation | - | - |
Dersalazine sodium | Phase 2 | Ulcerative Colitis | - | - |
Mesalamine | Phase 2 | Colonic Diverticulosis | - | - |
ADX10059 | Phase 2 | Gastroesophageal Reflux | - | - |
NOX-E36 | Phase 2 | Type 2 Diabetes Mellitus | - | - |
JTE-451 Tablets | Phase 2 | Plaque Psoriasis | - | - |
LP-003 Injection | Phase 2 | Allergic Asthma | - | - |
Imiquimod (topical use) | Phase 2 | Actinic Keratosis | - | - |
Zaleplon AP formulation | Phase 2 | Insomnia | - | - |
norUDCA | Phase 2 | Primary Sclerosing Cholangitis | - | - |
Low Dose GRT6005 | Phase 2 | Low Back Pain | - | - |
ATIR | Phase 2 | Acute Myeloid Leukemia | - | - |
PerioSept(r) | Phase 2 | Periodontitis | - | - |
Lexaptepid pegol (NOX-H94) | Phase 2 | Anemia | - | - |
Isotretinoin | Phase 2 | Congenital Ichthyosis | - | - |
ProTrans: Allogeneic transplantation with WJMSCs | Phase 2 | Type1 Diabetes Mellitus | - | - |
Utidelone | Phase 2 | HER2-negative Breast Cancer Patients With Brain Metastases | - | - |
ACT01 | Phase 2 | Actinic Keratosis | - | - |
ASP7517 | Phase 2 | Advanced Malignancies | - | - |
SPL026 | Phase 2 | Major Depressive Disorder | - | - |
GLS4 | Phase 2 | Chronic HBV Infection | - | - |
CRD007 | Phase 2 | Duchenne Muscular Dystrophy | - | - |
SFX-01 | Phase 2 | Subarachnoid Hemorrhage, Spontaneous | - | - |
CIN-107 | Phase 2 | Uncontrolled Hypertension | - | - |
Ibuprofen-PC | Phase 2 | Osteoarthritis | - | - |
Coated Nifedipine Suppositories | Phase 2 | Anal Resting Pressure | - | - |
Cabaletta for IV infusion once weekly during 24 weeks | Phase 2 | Machado-Joseph Disease / Spinocerebellar Ataxia 3 | - | - |
MT-8554 | Phase 2 | Painful Diabetic Peripheral Neuropathy | - | - |
Neflamapimod | Phase 2 | Dementia With Lewy Bodies | - | - |
QuickShot™ - Treatment B | Phase 2 | Hypogonadism | - | - |
PL3100 | Phase 2 | Gastroduodenal Ulcerations | - | - |
ONO-2506PO | Phase 2 | Alzheimer's Disease | - | - |
APO-go | Phase 2 | Parkinson Disease | - | - |
Calcipotriol | Phase 2 | Psoriasis Vulgaris | - | - |
ASP7147 | Phase 2 | Diarrhea Predominant Irritable Bowel Syndrome | - | - |
LEO 32731 | Phase 2 | Psoriasis Vulgaris | - | - |
DSP-7888 | Phase 2 | Myelodysplastic Syndrome | - | - |
ORM-12741 | Phase 2 | Alzheimer's Disease | - | - |
Nusivertib | Phase 2 | Myelofibrosis | - | - |
Tdap vaccine | Phase 2 | Atopic Dermatitis | - | - |
RPh201 | Phase 2 | Non-arteritic Ischemic Optic Neuropathy | - | - |
XER-001 | Phase 2 | Locally Advanced Pancreatic Adenocarcinoma | - | - |
Mavodelpar | Phase 2 | Primary Mitochondrial Myopathy | - | - |
A166 | Phase 2 | HER2-positive Breast Cancer | - | - |
INV-202 | Phase 2 | Obesity | - | - |
marketed topical retinoid | Phase 2 | Acne Vulgaris | - | - |
NMD670 | Phase 2 | Spinal Muscular Atrophy | - | - |
TA-NIC | Phase 2 | Smoking | - | - |
IZN-6N4 | Phase 2 | Oral Mucositis | - | - |
Phase 1: Trabectedin | Phase 2 | Soft-tissue Sarcomas | - | - |
Generalized Adult Periodontitis
1 drug in this indication
Brain Edema
1 drug in this indication
Congenital Adrenal Hyperplasia
1 drug in this indication
Prostate Cancer
1 drug in this indication
Schizophrenia
1 drug in this indication
Epilepsy
1 drug in this indication
Cerebral Palsy
1 drug in this indication
Asthma
1 drug in this indication
Aneurysmal Subarachnoid Hemorrhage
1 drug in this indication
Influenza
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in PharmaMar, S.A.'s drug pipeline?→
CatalystAlert tracks 813 drug candidates in PharmaMar, S.A.'s (PHM.MC) pipeline across Phase 3, Phase 2. Its lead program is Trabectedin (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PharmaMar, S.A.'s next FDA catalyst?→
PharmaMar, S.A.'s (PHM.MC) next tracked catalyst is a Phase 2 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track PHM.MC biotech catalysts?→
Add PHM.MC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PharmaMar, S.A.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
